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At several points in a woman’s life, changes in circulating estradiol
are associated with disturbances in mood and cognitive function.  To
determine the biological basis of these behavioral changes, researchers have
concentrated on the hippocampal formation, a medial temporal lobe
structure involved in the regulation of mood and cognition in humans.  It is
now clear that estradiol increases the substrates of hippocampal synaptic
plasticity, including dendritic spine density, synapse density, and synaptic
protein expression.  In some cases, these changes are associated with
alterations in mood and hippocampal-dependent learning and memory.  The
upstream mediators of these estradiol effects remain unknown, but likely
candidates may be inferred from known regulators of hippocampal synaptic
plasticity and estradiol effects in other tissues.
This thesis explored estradiol activation of two of these candidates,
PI3 kinase/Akt and brain-derived neurotrophic factor (BDNF), in the dorsal
hippocampus of female mice.  In naturally cycling and ovariectomized
female mice, estradiol increased hippocampal Akt and BDNF signaling as
determined by immunocytochemistry and in situ hybridization.  These
effects were associated with changes in synaptic protein expression, and
required specific estrogen receptor isoforms, as demonstrated using estrogen
receptor knockout mice. Immuno-electron microscopy revealed that
estradiol specifically increased signaling through presynaptic TrkB receptors
in Schaffer collateral and mossy fiber axons.  Estradiol effects on Akt
signaling were associated with changes in spatial memory ability, and were
profoundly altered in mice expressing the BDNF variant Val66Met.
This study therefore identifies Akt and BDNF signaling as important
upstream pathways in the control of hippocampal function by ovarian
steroids in vivo.   Circulating estradiol activates Akt rapidly  through a
BDNF-dependent mechanism, and increases expression of BDNF more
slowly, leading to increased activation of the BDNF receptor TrkB.  After
activation, Akt and TrkB may participate in estradiol regulation of spine
synapse density and hippocampal cell excitability.  Future studies should
aim to understand the specific role of Akt and BDNF in estradiol modulation
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In females, the sex hormone estradiol is released by the ovaries into
the circulation, and passes through the blood-brain-barrier to act directly on
the brain to control behavior.  Estradiol acts on brain regions controlling
both reproductive behaviors, and non-reproductive behaviors, such as mood
and cognition.  One of the most studied of these regions is the hippocampal
formation, a major center for the regulation of cognition and mood in
mammals. This brain region has been implicated in the pathology of many
human neuropsychiatric disorders, including Alzheimer’s disease, age-
related cognitive decline, depression, and bipolar disorder (Small et al.,
2004; deToledo-Morrell et al., 2007; Frey et al., 2007; Maletic et al., 2007).
Estradiol may be an important factor controlling hippocampal function and
susceptibility to these disorders.
Estradiol affects hippocampal function in animals and humans
In rodents and nonhuman primates, the function of the dorsal
hippocampal formation (known as the posterior hippocampal formation in
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humans and hereafter referred to as the hippocampal formation) is often
assessed using (among others) tests of spatial learning and memory, which
animals with hippocampal lesions are unable to perform successfully
(Squire, 1992; Packard and McGaugh, 1996; Bannerman et al., 2004; Good
et al., 2007).  In humans, the hippocampus is essential for spatial navigation,
and declarative and episodic memory, and its function is often assessed
using tests of verbal recall (Squire, 1992).  Studies of laboratory rodents,
nonhuman primates, and humans performing these hippocampal-dependent
tasks have shown that estradiol generally enhances hippocampal function.
Suppression of ovarian function causes a decrement in hippocampal-
dependent learning and memory, suggesting that endogenous estradiol
maintains hippocampal function. For example, in rats, ovariectomy impairs
object recognition memory, and estradiol replacement corrects this deficit
(Luine et al., 2003; Wallace et al., 2006).  Similarly, ovariectomy impairs
performance of rats on the hippocampal-dependent active avoidance
paradigm, a deficit corrected by 5 weeks of estradiol replacement (Singh et
al., 1994).  Young adult women given a gonadotropin releasing hormone
agonist to suppress ovarian function exhibit verbal memory deficits that can
be corrected with estradiol replacement (Sherwin and Tulandi, 1996;
Berman et al., 1997).
3
Evidence that the estradiol enhancement of these tests indeed
represents direct effects on hippocampal function comes from studies
showing enhanced performance with estradiol infusion directly into the
hippocampus, but not other brain regions (Packard and Teather, 1997b;
Zurkovsky et al., 2006). Estradiol’s ability to enhance performance on
hippocampal-dependent learning and memory tasks in female rats (Daniel et
al., 1997; Luine et al., 1998; Korol and Kolo, 2002; Sandstrom and
Williams, 2004; Frye et al., 2007), mice (Li et al., 2004; Xu and Zhang,
2006), and rhesus monkeys (Lacreuse et al., 2002; Rapp et al., 2003a) may
be due in part to an improvement in memory consolidation, because
estradiol treatment immediately after  training on spatial memory tasks still
enhances performance on subsequent test trials (Packard and Teather, 1997a;
Luine et al., 2003; Gresack and Frick, 2006).
Natural fluctuations in circulating estradiol also affect performance on
hippocampal-dependent tasks.  In female rats, spatial memory fluctuates
across the estrous cycle, with the best performance during proestrus when
circulating estradiol is high (Korol et al., 2004; Frye et al., 2007).  In
women, some studies have found that verbal memory and hippocampal
activation fluctuate across the menstrual cycle and correlates positively with
serum estradiol levels (Rosenberg and Park, 2002; Sherwin, 2003; Dreher et
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al., 2007; Protopopescu et al., 2008).  This suggests that natural increases in
circulating estradiol also enhance hippocampal function in rodents and
humans.
In addition to the large literature suggesting that estradiol enhances
hippocampal function, some studies have found impaired learning and
memory with increased circulating estradiol.  In one such study,, rats
showed impaired spatial learning in the Morris water maze task during
proestrus (Warren and Juraska, 1997).  Spatial abilities were also impaired in
women during the midluteal phase of the menstrual cycle (high circulating
ovarian steroids) relative to the menstrual phase (low circulating steroids)
(Hampson, 1990).  From estradiol replacement studies it is clear that many
factors govern how estradiol will influence learning and memory, including
the treatment paradigm and the specific demands of the cognitive task
(Frick, 2009).
Estradiol enhances hippocampal synaptic plasticity
The discovery that estradiol enhances hippocampal function pointed
to the possibility that it might directly affect hippocampal synaptic plasticity.
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Synaptic plasticity includes experience-dependent modifications that are
increasingly implicated in learning and memory.  These include structural
modifications of spine synapses, electrical long-term potentiation, and
increased expression of key synaptic proteins (Engert and Bonhoeffer, 1999;
Muller et al., 2000; Whitlock et al., 2006; Yashiro and Philpot, 2008; Costa-
Mattioli et al., 2009).  Indeed, estradiol targets all of these forms of synaptic
plasticity.
Spine structure modification.   In female rats, ovariectomy decreases
the density of dendritic spines in the CA1 stratum radiatum of the
hippocampus, an effect rescued by 72 hours of estradiol replacement (Gould
et al., 1990; Woolley et al., 1990; Woolley and McEwen, 1992).  Estradiol
also increases spine density in rat primary hippocampal neurons in culture,
where 48 hours of exposure to 0.1 µg/mL estradiol doubles the dendritic
spine density (Murphy and Segal, 1996). A similar fluctuation of spine and
synapse density also occurs across the estrous cycle: rats in proestrus (high
circulating estradiol) show 30% higher spine densities in the CA1 region
than rats in estrus (low circulating estradiol) (Woolley et al., 1990).
Proestrus rats also have a higher proportion of spines with large heads, or
“mushroom” shapes (Gonzalez-Burgos et al., 2005).  In mice, estradiol
treatment increases the density of these mushroom spines in the CA1 stratum
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radiatum (Li et al., 2004).  Mushroom spines have a larger head,
accommodating larger and more complex post-synaptic densities (Bourne
and Harris, 2008).  They are widely considered to be functionally stronger
and more stable than other spine types, and their density increases with
learning (Tada and Sheng, 2006; Hongpaisan and Alkon, 2007; Bourne and
Harris, 2008).  The effects of estradiol on total and mushroom spine density
suggest that it facilitates both the formation of new spine synapses, and the
strengthening of existing connections.  Indeed, electron microscopy studies
showed that estradiol does indeed increase synapse density, measured as an
increase in excitatory-type synaptic contacts and multi-synaptic boutons, in
female rats (Woolley and McEwen, 1992; Woolley et al., 1996).  Estradiol
also enhances ultrastructural correlates of synapse strength, including
postsynaptic density thickness and synaptic vesicle number, in the CA1 of
female mice (Xu and Zhang, 2006).
Excitability and long-term potentiation.  The first report on the
modulation of hippocampal electrical activity by ovarian steroids was
published almost forty years ago, describing electrical changes in the limbic
system across the estrous cycle of the female rat (Terasawa and Timiras,
1968).  Since then, other groups have demonstrated that estradiol increases
hippocampal excitability in the rat (Kim et al., 2006; Scharfman and
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MacLusky, 2006; Smith and McMahon, 2006).  Estradiol also enhances
long-term potentiation (LTP) in awake rats (Cordoba Montoya and Carrer,
1997) and cultured hippocampal slices (Foy et al., 1999; Foy et al., 2008).
Across the estrous cycle, hippocampal excitability and LTP at CA3-CA1
synapses are enhanced during proestrus compared to other cycle stages in
anesthetized female rats (Warren et al., 1995; Good et al., 1999; Scharfman
et al., 2003).  Together, these findings suggest that both physiological and
pharmacological increases in circulating estradiol increase hippocampal
excitability and enhance long-term potentiation in female rats.
Synaptic protein expression.  Excitatory synapses on hippocampal
pyramidal cells contain a host of specialized synaptic proteins important for
synaptic function.  At the postsynaptic side, these include the scaffolding
protein PSD-95 and actin-binding protein spinophilin, both involved in
activity-dependent spine synapse dynamics (El-Husseini et al., 2000; Feng et
al., 2000; Ehrlich et al., 2007).  Presynaptically, synaptophysin is a synaptic
vesicle protein commonly used to localize synapses and implicated in spatial
memory ability (Smith et al., 2000; Valtorta et al., 2004), and syntaxins are a
family of SNARE proteins involved in synaptic vesicle release.   Estradiol
has been shown to increase the expression of these proteins in mice, rats, and
nonhuman primates.  Forty-eight hours of estradiol treatment increases
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immunoreactivity for all four synaptic proteins in the rat hippocampus
(Brake et al., 2001; Lee et al., 2004b; Waters et al., 2006).  In mice, six days
of estradiol treatment increases PSD-95, spinophilin, and syntaxin
expression in all hippocampal subregions (Li et al., 2004). One month of
estradiol treatment increases synaptophysin, syntaxin, and spinophilin
expression in the CA1 strata radiatum and oriens of ovariectomized female
rhesus monkeys (Choi et al., 2003).  Estradiol likely acts directly on neurons
to increase the expression of these synaptic proteins, since estradiol
treatment increases PSD-95 expression in the NG108-15 neuroblastom cell
line in vitro (Akama and McEwen, 2003).
Neurotransmitter systems. NMDA receptors are ubiquitously found at
excitatory synapses.  They are essential for long-term potentiation and
learning-induced dendritic spine dynamics (Miyamoto, 2006; Fedulov et al.,
2007).  Ovariectomy causes a decrease NMDA receptor binding and
expression of the NR1 and NR2B receptor subunits in the rat hippocampus
(Cyr et al., 2001b; Cyr et al., 2001a), and estradiol replacement increases
these measures (Weiland, 1992a; Gazzaley et al., 1996; Woolley et al., 1997;
Romeo et al., 2005).  Estradiol’s effects on NMDA receptors may be
important for it to increase dendritic spine density and LTP, as both these
effects are blocked by NMDA receptor antagonists (Woolley and McEwen,
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1994; Smith and McMahon, 2006). Estradiol also modulates inhibitory
inputs in the hippocampus, inducing a transient decrease in GABAergic
inhibition followed by a recovery of the inhibition and an increase in GAD
expression (Weiland, 1992b; Murphy et al., 1998; Rudick and Woolley,
2001).  The effects of estradiol on GABAergic transmission may be specific
to different subtypes of GABAergic neurons (Nakamura and McEwen,
2005; Scharfman and Maclusky, 2006; Hart et al., 2007; Nakamura et al.,
2007).  Finally, estradiol enhances cholinergic transmission by acting
directly in the hippocampus and also on hippocampal afferents originating in
the basal forebrain (Gibbs et al., 1994; Gibbs, 1997; Daniel and Dohanich,
2001; Marriott and Korol, 2003; Rudick et al., 2003).  Cholinergic
transmission is essential for estradiol to enhance hippocampal-dependent
memory (Daniel and Dohanich, 2001).
In sum, estradiol enhances hippocampal synaptic plasticity in multiple
domains.  Its effects on dendritic spine dynamics, electribal activity, and
protein expression in neurons serve to augment hippocampal cell excitability
in general, and to enhance specific activity-dependent modifications. These
effects may underly estradiol’s ability to enhance hippocampal-dependent
learning and memory.  They may also underly the estradiol impairment of
learning and memory seen in several studies.  Experimenter-induced
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synaptic potentiation and increased synapse density, similar to to effect of
estradiol, can occlude subsequent hippocampal-dependent learning
(Madronal et al., 2007; Barbosa et al., 2008).  Indeed, the relationship
between spine shape and hippocampal function is not always
straightforward: mice missing the postsynaptic scaffolding protein Shank
have smaller spines and weaker synaptic transmission, but better hippocapal-
dependent learning (Hung et al., 2008).
Although most of the studies of estradiol effects on hippocampal
synaptic plasticity were conducted in female rats, conservation of estradiol
effects on synaptic protein expression in mice, rats, and nonhuman primates
raises the possibility that they are also conserved in humans.  This possible
human relevance increases the urgency of determining how estradiol
signaling leads to its enhancement of synaptic plasticity.
Estradiol acts on estrogen receptors via nuclear- and membrane-
intiated signaling
Numerous studies have provided evidence that estradiol effects in the
hippocampal formation depend on estrogen receptors (ERs).  For example,
pharmacological ER antagonism blocks estradiol-mediated pyramidal cell
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disinhibition and spinogenesis in the rat hippocampus (McEwen et al., 1999;
Rudick et al., 2003).   There are two types of classical ER, alpha and beta,
which are expressed in the mouse, rat, and monkey hippocampal formation
(Shughrue et al., 1997; Weiland et al., 1997; Register et al., 1998; Mitra et
al., 2003).  Knockout of either receptor in female mice impairs hippocampal-
dependent learning (Fugger et al., 2000; Rissman et al., 2002; Day et al.,
2005), and both have been implicated in hippocampal spinogenesis and
synaptic protein expression (Szymczak et al., 2006; Mukai et al., 2007;
Spencer et al., 2008).  Nevertheless, these receptors may activate distinct
mechanisms.  Knockout of ER beta impairs LTP (Day et al., 2005), while
knockout of ER alpha but not ER beta eliminates estradiol’s ability to
increase spinophilin expression (Spencer et al., 2008).  Much work remains
to discover the distinct actions of each estrogen receptor in the hippocampal
formation, and which actions are necessary for estradiol’s effects on
hippocampal function.  The distinction between the roles of ER alpha and
ER beta will be especially important as laboratory work is translated to
clinical studies. ER alpha and beta have different expression profiles
throughout the body and in the brain that will be important in considering
the efficacy and side effects of estrogenic agents (Shughrue et al., 1997;
Shang and Brown, 2002).
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Estrogen receptors engage in two modes of signaling: nucleus- or
membrane-initiated steroid signaling (Levin, 2005; Hammes and Levin,
2007; Vasudevan and Pfaff, 2007).  In nucleus-initiated signaling,
cytoplasmic ERs bound to estradiol translocate to the nucleus and bind
estrogen response elements (EREs) in the DNA to influence gene
transcription (Hammes and Levin, 2007).  In membrane-initiated signaling,
extranuclear estrogen receptors affiliated with the plasma membrane or
membranous organelles couple to G proteins, growth factor receptors, and
intracellular kinases to activate signaling events (Pedram et al., 2006b;
Hammes and Levin, 2007; Pedram et al., 2007).  The resulting signaling
cascades can act on transcription factors to affect gene transcription, or
effect more rapid changes independent of new gene transcription (Levin,
2005; Mannella and Brinton, 2006; Pedram et al., 2006a).
Very few nuclear ERs are found in the hippocampal formation.  Work
in the McEwen laboratory has shown that nuclear estradiol binding and ER
alpha-immunoreactivity is found in scattered inhibitory GABAergic
interneurons in the rat hippocampal formation (Loy et al., 1988; McEwen
and Milner, 2007).  In contrast, neurons in the rat hippocampal formation
contain no detectable nuclear ER beta, although some can be found in
astrocytes (Azcoitia et al., 1999; Milner et al., 2005). This suggests that
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estradiol may modulate GABAergic neurotransmission and astrocyte
function through nucleus-initiated signaling.
The near-absence of nuclear ER alpha and beta in pyramidal cells, the
principal excitatory neurons in the hippocampal formation, suggests that
estradiol may signal through membrane-associated receptors in these cells.
Indeed, estradiol binding and ultrastructural studies from the McEwen lab
and others have identified extranuclear estrogen receptors in neurons of the
rat hippocampal formation (Shughrue and Merchenthaler, 2000; Milner et
al., 2001; Mitra et al., 2003; Kalita et al., 2005; Milner et al., 2005; Milner et
al., 2008).  Electron microscopy studies have revealed distinct distributions
of the two receptor subtypes: ER alpha is found mostly in axons and axon
terminals and to a lesser degree in dendritic spines, while extranuclear ER
beta is mainly affiliated with the membrane of somata and dendrites of
principle cells (McEwen and Milner, 2007).  These different distributions
indicate that ER subtypes may play different roles in the maintenance of
hippocampal function.
Several pieces of evidence suggest that membrane-initiated signaling
mediates estradiol effects on hippocampal function.  First, many estradiol
effects on signal transduction and synaptic potentiation in hippocampal
neurons occur too quickly to be mediated by nucleus-initiated signaling.
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The effects of estradiol on gene transcription are visible 12-24 hours after
hormone exposure (Vasudevan et al., 2001; Gottfried-Blackmore et al.,
2007), while signaling pathway activation can be measured from 15 minutes
through six hours of continuous estradiol exposure (Akama and McEwen,
2003; Abraham et al., 2004; Lee et al., 2004a; Yuen, 2006; Fernandez et al.,
2008). In keeping with these rapid effects, estradiol enhancement of spatial
memory can be achieved by administration immediately, but not two hours,
after training, suggesting a rapid effect of the hormone on memory
consolidation during this narrow two-hour time window following training
(Packard and Teather, 1997a; Luine et al., 2003; Gresack and Frick, 2006).
In addition, estradiol increases PSD-95 and spinophilin expression through a
post-transcriptional mechanism, suggesting the involvement of membrane-
initiated signaling (Piva et al., 1995; Quinones-Jenab et al., 1997; Akama
and McEwen, 2003; Lee et al., 2004b).  Finally, compounds designed as
antagonists at nuclear ERs have in fact shown some estrogenic properties in
the brain.  For example, the estrogen receptor antagonist ICI 182,780 acts as
an agonist to enhance spatial learning when infused directly into the
hippocampus of female rats (Zurkovsky et al., 2006).  Low doses of 17-
alpha estradiol, an isomer of the natural 17-beta estradiol, have no effect on
lipid metabolism or uterine weight but rapidly enhance spatial memory and
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increase CA1 spine synapse density in ovariectomized rats within four hours
of subcutaneous injection (Lundeen et al., 1997; MacLusky et al., 2005).
This evidence suggests that these compounds act through mechanisms other
than the classical nucleus-initiated signaling to achieve these effects in the
brain.
The evidence gathered therefore points to both rapid and delayed
effects of estradiol in different hippocampal cell types, with an emphasis on
the importance of extranuclear ERs in hippocampal pyramidal cells.  In
addition to the classical ERs alpha and beta, novel membrane ERs such as
the ER-X, (Toran-Allerand et al., 2002) and the G-protein receptor, GPR30
(Bologa et al., 2006), may participate.  Thus it is clear that many questions
still remain in the investigation of how estradiol affects hippocampal
function.
Mechanism of estradiol enhancement of hippocampal synaptic plasticity
Because of the numerous types of ER and their multiple modes of
signaling, the mechanism of estradiol enhancement of hippocampal function
is undoubtedly complex.  Elucidation of the key upstream mediators will be
an important step toward understanding this process.  Studies conducted
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mostly in cultured hippocampal neurons have identified several candidate
mediators, including the extracellular signal-related kinase (ERK) pathway,
phosphoinositol-3-kinase (PI3K) pathway, and brain-derived neurotrophic
factor (BDNF).
ERK and CREB.  Estradiol treatment leads to activation of the cyclic
AMP response element binding protein in the dorsal hippocampus of female
rats and mice (Bi et al., 2001; Abraham et al., 2004; Zhou et al., 2005).  In
cultured primary and immortalized neurons, estradiol activates CREB via
the ERK pathway (Wade and Dorsa, 2003; Lee et al., 2004a; Mannella and
Brinton, 2006; Szego et al., 2006).  This mechanism may also operate in
vivo, as estradiol rapidly activates ERK in the mouse hippocampus, and
ERK2 activation fluctuates across the estrous cycle in female rats (Bi et al.,
2001; Fernandez et al., 2008).  The importance of the ERK pathway in
synaptic plasticity and memory (Sweatt, 2004) suggest that estradiol
activation of MAPK/CREB may be responsible for some of its effects on
hippocampal synaptic plasticity and behavior.  CREB phosphorylation has
been implicated in estrogen-induced spine formation and upregulation of
synaptic protein expression in primary cultured hippocampal neurons
(Murphy and Segal, 1997; Zhao et al., 2005). Moreover, hippocampal
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infusion of an ERK inhibitor blocks estradiol enhancement of an object
recognition task in female mice (Fernandez et al., 2008).
PI3K/Akt.  The PI3Ks are a family of protein kinases implicated in a
wide array of neuronal functions, including cell survival and long-term
potentiation (Sanna et al., 2002; Sui et al., 2008; Yang et al., 2008).  They
catalyze the phosphorylation of phosphoinositols to form signaling
intermediates such as phosphatidylinositol-3,4,5-triphosphate (PIP3). The
formation of these intermediates leads to activation of several serine-
threonine kinases including Akt (also known as Protein Kinase B).  The
well-known role of Akt in cell survival has led several investigators to
hypothesize and demonstrate the importance of this pathway in estradiol-
mediated neuroprotection (Du et al., 2004; Suzuki et al., 2006; Morissette et
al., 2007).  More recently, the McEwen lab and others have begun to
elucidate a specific role for Akt in estradiol regulation of spine synapse
remodeling and synaptic protein expression.  Estradiol activates Akt in the
NG108-15 neuroblastoma cell line, and PI3K/Akt signaling in these cells is
important for estradiol induction of PSD-95 expression (Akama and
McEwen, 2003; Yuen, 2006).  This induction occurs rapidly via an increase
in protein translation.  Estradiol also activates Akt in the CA1 stratum
radiatum of the rat hippocampus.  Immunoreactivity for phosphorylated Akt
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(pAkt), the activated form, increases in the CA1 stratum radiatum of
proestrus and estradiol-replaced rats relative to ovariectomized rats and rats
in other estrous cycle stages (Znamensky et al., 2003).
BDNF/TrkB. BDNF, part of the neurotrophin family, is a peptide
critical for neuronal differentiation, growth, and survival in the developing
nervous system.  In the adult hippocampus, BDNF supports protein-
synthesis-dependent LTP, spine structure modification, and memory (Kang
and Schuman, 1995; Messaoudi et al., 2002; Bekinschtein et al., 2008;
Tanaka et al., 2008). The numerous similarities between the effects of
estradiol and BDNF on hippocampal physiology and behavior have led
several investigators to hypothesize a role for BDNF in estrogen effects on
this brain region (Scharfman et al., 2003; Scharfman and Maclusky, 2005,
2006; Sohrabji and Lewis, 2006).  Estradiol increases BDNF mRNA and
protein expression in the hippocampus of ovariectomized rats (Gibbs, 1998;
Jezierski and Sohrabji, 2001; Scharfman et al., 2003; Zhou et al., 2005;
Scharfman et al., 2007).  In addition, levels of BDNF mRNA and protein
fluctuate across the estrous cycle in female rats (Gibbs, 1998), with the
highest protein expression during proestrus (Scharfman et al., 2003;
Scharfman et al., 2007).
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There are several possible mechanisms by which estradiol may
increase BDNF expression. A putative ERE has been identified in the rat
BDNF gene (Sohrabji et al., 1995), whose sequence is preserved in mouse
and human, that binds estrogen receptor-ligand complexes in vitro.
Estradiol could in this way activate transcription of the BDNF gene in
hippocampal interneurons containing nuclear ERs. In hippocampal
pyramidal cells that do not contain nuclear ERs, estradiol activation of
another transcription factor could increase BDNF expression.  One
possibility is the cyclic AMP response element binding protein (CREB),
which is phosphorylated by estradiol in hippocampal neurons (Abraham et
al., 2004; Lee et al., 2004a; Szego et al., 2006).  CREB activates
transcription at cyclic AMP response element (CRE) sites in DNA, one of
which is contained in the BDNF promoter region (Tao et al., 1998).
Estradiol activation of CREB via membane-associated ERs could therefore
activate BDNF gene transcription via its CRE site.
BDNF signals through high-affinity interaction with its specific
receptor, tropomyosin-related kinase B (TrkB), and low-affinity interaction
with the P75 neurotrophin receptor (P75NTR).  Activation of TrkB is
involved in spatial memory formation in rats (Mizuno et al., 2003a), raising
the plausible hypothesis that TrkB signaling may mediate the effects of E-
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induced BDNF expression on spatial memory.  In addition, signaling
through TrkB leads to Akt activation (Chao, 2003; Schratt et al., 2004), and
postsynaptic knockout of TrkB decreases a mature subset of spines in the
mouse hippocampal CA1 region (Chakravarthy et al., 2006), suggesting that
TrkB activation could amplify estrogen effects on Akt activation and
facilitate spine maturation.  Indeed, a few reports provide evidence for TrkB
signaling as a mediator of estradiol effects in the brain.  In rat hippocampal
slices, TrkB inhibitors block the estradiol-mediated increase in hippocampal
excitability, PSD-95 expression, and dendritic spine formation (Scharfman
et al., 2003; Sato et al., 2007).  Taken together these findings demonstrate
that in the female rat, estradiol increases BDNF expression, and that BDNF
signaling through TrkB may contribute to estradiol enhancement of
hippocampal synaptic plasticity.
Rodent models
Most of the in vivo research on the mechanism of estradiol effects in
the hippocampal formation has been conducted in rats.  Despite the
historical utility of the rat for these investigations, the mouse is an attractive
model for in vivo work because of the ease of genetic manipulation, which
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affords opportunities for direct mechanistic investigation. For example, one
group investigated the importance of ERs in CREB activation using estrogen
receptor knockout mice.  They found that ER beta, but not ER alpha,was
necessary for estradiol to activate CREB in the CA1 stratum radiatum
(Abraham et al., 2003).  Despite the clear utility of these knockout mice, and
the easy availability of many other mouse models with useful genetic
manipulations, few investigators currently study estradiol effects in the
mouse hippocampus.
Previous work has uncovered a few differences in the effects of
estradiol in rat and mouse that may inhibit investigators from crossing
species.  For example, while estradiol increases synaptic protein expression
most potently in the CA1 region of the rat hippocampus, it induces a
widespread increase in synaptic protein expression throughout the mouse
hippocampal formation (Brake et al., 2001; Li et al., 2004).  Additionally,
although estradiol increases the total dendritic spine density in the rat (Gould
et al., 1990; Gonzalez-Burgos et al., 2005), it increases only the density of
“mushroom” shaped spines in the mouse CA1 (Li et al., 2004).  Finally, in
the dentate gyrus, neurogenesis increases after estradiol treatment in the rat,
but not the mouse (Lagace et al., 2007; Galea, 2008).
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Though these mouse/rat differences in estradiol sensitivity may be
real and important, the many similarities in estradiol effects on spine shape,
synaptic protein expression, spatial memory, and ERK/CREB activation
suggest that the mechanisms of estradiol effects may be similar in mouse
and rat.  Akt and BDNF are therefore very promising candidate mediators of
estradiol effects in mice based on their sensitivity to estradiol in both
hippocampal culture and rat hippocampus in vivo. I set out to investigate
whether these two molecules are affected by estradiol in the mouse
hippocampal formation.
Study design
In rats, estradiol effects on hippocampal Akt and BDNF have been
seen with natural increases in circulating estradiol during proestrus, and with
estradiol injection after ovariectomy (Scharfman et al., 2003; Znamensky et
al., 2003; Scharfman et al., 2007).  The primary goal of the work in this
thesis was to understand the effects of estradiol on Akt and BDNF in the
mouse hippocampal formation.  Both naturally cycling and ovariectomized
mouse models were used to investigate the effects of natural and
pharmacologic increases in circulating estradiol. Akt activation, BDNF
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expression, and TrkB expression and activation were measured in the dorsal
hippocampal formation using immunocytochemistry and in situ
hybridization. The relationship of estradiol effects on Akt and BDNF
signaling to downstream effects on expression of the synaptic protein, PSD-
95, was determined using immunocytochemistry.  The studies took
advantage of pre-existing transgenic mouse lines to explore the mechanisms
of estradiol effects on these endpoints.  Mice with targeted deletions of each
receptor were used to determine role of estrogen receptors alpha and beta in
these effects using.  Electron microscopy was used to study the
ultrastructural details of estradiol effects on TrkB activation.  In the final
study, I considered how a common human polymorphism in the BDNF gene,
Val66Met, affects cognitive behavior and the natural fluctuation of these
molecular endpoints across the estrous cycle.
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Chapter 2
A murine model to study estradiol effects in the hippocampus
C57Bl/6J mice were chosen for all the following studies based on
their common use for the back crossing of transgenic lines.  For the most
complete study of estradiol effects in the hippocampal formation, studies
were designed using both naturally cycling mice and ovariectomized mice
replaced with estradiol.  However, there were no papers in the literature with
a detailed description of the characteristics of the estrous cycle in this mouse
strain.  This was therefore the necessary starting place to be able to
meaningfully study estradiol effects in the mouse hippocampal formation.
For a detailed characterization of the estrous cycle in these mice, cycles were
monitored for several weeks using vaginal smear cytology.  The mice were
then sacrificed in difference estrous cycle stages for measurements of uterine
weights and circulating levels of estradiol and progesterone.
In addition to the characteristics of the estrous cycle, the location of
estrogen receptors in the hippocampal formation is essential information in
order to draw conclusions about how estradiol affects this brain region.  The
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first localization of estrogen receptors in the mouse hippocampus, using light
microscopy, suggested similarities with the rat (Mitra et al., 2003).
Extensive extranuclear ER beta was found, most notably in fibers in the CA1
stratum radiatum and CA3 stratum lucidum.  In contrast, extranuclear ER
alpha was light and not easily discernable using light microscopy, but
scattered nuclear ER alpha was found throughout the hippocampal formation
that could indicated expression in interneurons, similar to the rat.  In order to
make more meaningful comparisons between the species, I collaborated with
Dr. Teri Milner and Katherine Mitterling at Weill Cornell Medical College
to perform an ultrastructural localization of ERs alpha and beta in the mouse
hippocampal formation.
C57BL/6J mice have regular cycles with predictable hormone levels and
uterine weights
The mice had uniform estrous cycles with an average length of 6.1 +/-
0.30 days (Figure 2.1).  Mice spent an average of 1.1 days in proestrus, 2.5
days in estrus, and 2.5 days in diestrus.  Uterine weights and plasma
hormone measurements were conducted on mice sacrificed in proestrus,
estrus, and early or late diestrus, termed diestrus 1 and diestrus 2.
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Figure 2.1 C57Bl/6J mice have regular estrous cycles. The C57BL6
female mice used in this study had regular, 6.1-day estrous cycles.  As
assessed by daily morning vaginal smears, 1.1 days (18%) of the cycle were
spent in proestrus, 2.5 days (41%) in estrus, and 2.5 days (41%) in diestrus.
Mice perfused as indicated with arrows in proestrus, early estrus, diestrus 1
and diestrus 2 for uterine weight and serum ovarian steroid measurements.
Error bars show standard error of the mean.
Estradiol levels peaked during proestrus, and were low in all other stages
(Figure 2.2).  In contrast, progesterone levels rose during estrus and
remained elevated until diestrus 2.  Because of the large variation in
circulating hormone levels across the cycle, circulating estradiol and
progesterone averages are pictured as a schematic.
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Figure 2.2 Hormone levels and uterine weights fluctuate across the
mouse estrous cycle.  Average plasma estradiol and progesterone levels are
shown as a schematic, due to the large amount of variation among animals,
while uterine weights are shown with error bars as standard error of the
mean.  Uterine weights were significantly increased in proestrus compared
to all other cycle stages.  N = 3 for diestrus 2, 6 for proestrus, 5 for estrus,
and 5 for diestrus 1.
One-way ANOVA comparing uterine weights showed that uteri were
significantly heavier in proestrus than in other cycle phases (Figure 2.2; F
(3,15) = 7.793, p = 0.0023, post-hoc tests show proestrus greater than all
other groups, p<0.05).
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The mouse hippocampal formation contains extranuclear ERs
ERs alpha and beta were localized using isoform-specific antibodies
with light and electron microscopy.  The specificity of the ER antibodies has
previously been confirmed using more than one method for each antibody
(see Chapter 8, Materials and Methods).  Specificity was not tested in ER
knockout mice, as these mice were created using targeted disruptions of the
ER genes and express some nonfunctional ER peptides that the antibody
may recognize.
ER alpha and beta labeling was found almost exclusively outside the
nucleus.  Light microscopy revealed a few scattered pyramidal cell nuclei
with ER alpha labeling, and electron microscopy revealed some ER beta
labeling within principal cell perikarya. The electron microscopic
localization revealed extensive extranuclear ER alpha and beta
immunoreactivity (ir), with differences in the distribution of the two
receptors (Tables 2.1 and 2.2).
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Table 2.1 Distribution of ER alpha-immunoreactivity in the mouse
hippocampal formation.  ER alpha-labeled profiles were counted from a
2,646 µm2 area in each hippocampal lamina of 12 male and female mice.
Numbers represent the average number of each type of labeled profile in
each lamina per mouse.
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Table 2.2 Distribution of ER beta-immunoreactivity in mouse
hippocampal formation. ER beta-labeled profiles were counted from a
2,646 µm2 area in each hippocampal lamina of 12 male and female mice.
Numbers represent the average number of each type of labeled profile in
each lamina per mouse.
Both ERs were found at synapses, including postsynaptic dendritic spines
and presynaptic axon terminals (Figures 2.3 and 2.4).  ER alpha was very
prominent in axons and glia, and less prominent in dendrites.  Dendritic ER
beta-ir was much more common than dendritic ER alpha-ir.  ER beta was






Figure 2.3 Extranuclear ER alpha-ir in mouse hippocampal formation. 
ER alpha immunoreactivity is found in select dendrites, axons, terminals, 
and glia in males and female mice at all stages of the estrus cycle.  (A) ER 
alpha labeling is seen in a dendritic shaft at the base of a spine (ERa-S; 
arrowhead) in the middle molecular layer of the dentage gyrus. (B) An ER 
alpha-labeled dendritic spine is shown making a synapse (curved arrow) 
with an unlabeled terminal (uT) in CA1 stratum radiatum.  An unlabeled 
spine is also shown (uS).  (C) An ER alpha-labeled terminal (ERa-T; 
arrowhead) is shown making a synapse with an unlabeled dendritic spine 
(curved arrow) in CA3 stratum oriens.  (D) ER alpha labeling is shown in a 
longitudinal view of an unmyelinated axon (ERa-A) in CA3 stratum 
radiatum.  An unlabeled axon (uA) is also shown for comparison. (E) ER 
alpha labeling is found in an unmyelinated axon leading to an unlabeled 
terminal in CA3 stratum lucidum. (F) ER alpha labeling was also found in a 
myelinated axon (ERa-mA; arrowhead) in CA3 stratum oriens.  G.  An ER 
alpha-labeled glia (ERa-g) is found apposed to an unlabeled dendritic spine 


























Figure 2.4 Extranuclear ER beta-ir in mouse hippocampal formation.  
(A) ER beta labeling is seen throughout the perikarya (arrowhead) in CA1 
stratum radiatum.  Inset shows labeling at a higher magnification (Scale bar, 
250 nm).  (B) An ER beta-labeled spine (ERb-S) of an unlabeled dendrite 
(uD) makes a synapse with an unlabeled terminal (uT) in CA1 stratum 
oriens.  (C) ER beta labeling is found in a dendrite (ERb-D), both in the 
cytoplasm (black arrowhead) and on a mitochondrion (white arrowhead), in 
CA1 stratum radiatum. (D) ER beta labeling is found in a glia (ERb-g) in 
CA1 stratum radiatum.  Scale bar, 250 nm.  (E) An ER beta-labeled terminal 
(ERb-T; arrowhead) is shown making a synapse with an unlabeled spine 
(uS; curved arrow) in CA1 stratum radiatum (CA1 sr).  Bar 250nm  F.  An 
ER beta-labeled glia is shown near a blood vessel (bv).  All images were 
taken from CA1 stratum radiatum except where noted.  Scale bars, 0.5 μm 













   







These data suggest that the C57Bl/6J mouse is a suitable animal
model for studies based on natural fluctuations in ovarian steroids.  Cycle
lengths are consistent between and within animals, facilitating the practical
aspects of these studies.  By definition, an estradiol surge occurs during
proestrus that makes the mouse receptive for sexual activity (Turner and
Bagnara, 1971a). On the late morning when vaginal smears showed
exclusively the nucleated epithelia characteristic of proestrus, plasma
estradiol levels in the mice were increased (but variable) and uterine weights
were uniformly increased.  When circulating estradiol increases, it acts
directly on the uterus to increase water content and blood flow within six
hours, followed by endometrial cell proliferation and hypertrophy within 12-
24 hours (Couse et al., 1995).  These two responses were not distinguished
in this study, allowing the conclusion that in these mice, estradiol levels
began to increase 6-24 hours prior to the late morning of proestrus, when
uterine weights were clearly elevated.  In rats and CD-1 mice, circulating
estradiol begins to rise during late diestrus (Walmer et al., 1992; Staley and
Scharfman, 2005).  In the current study, late diestrus vaginal cytology was
observed 24 hours before proestrus in C57Bl/6 mice.  Thus circulating
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estradiol likely increased gradually over the 24 hours prior to the late
morning of proestrus.  This makes the late morning an appropriate time point
for the observation of both rapid estradiol effects on signaling pathways and
more delayed actions requiring new gene transcription.
The ultrastructural localization of ERs alpha and beta in the mouse
hippocampal formation showed that, as in the rat, these receptors are located
almost exclusively outside the nucleus (Milner et al., 2001; Milner et al.,
2005).  The receptors had a distinct but overlapping distribution that could
be important for the downstream effects of estradiol in this brain region.
The synaptic localization of both receptors positions them for local
modulation of synaptic transmission and spine morphology. The relatively
greater amount of ER alpha in axons, found in both mouse and rat, suggests
that estradiol may activate different pathways in axons and dendrites due to
the ratio of ERs found in these processes.  Finally, the localization of ERs to
glial profiles suggests that distinctions between estradiol effects in neurons
and glia would be useful to explore in future studies.  Overall, the
similarities in the distribution of ER alpha and beta in the mouse and rat
hippocampal formation suggest that the effects of estradiol in this brain
region will be similar.  Any species differences in estradiol effects in the
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hippocampal formation may not be attributable to different receptor
localizations.
In sum, this chapter puts forward the C57Bl/6J mouse as a useful
model for studies of estradiol effects in the hippocampal formation.  These
mice have regular estrous cycles with expected vaginal cytology, circulating
hormone levels, and uterine weights, which will enable studies of natural
fluctuations of estradiol.  ERs alpha and beta are found primarily in
extranuclear locations, well position for membrane-initiated steroid
signaling in both neurons and glia.
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Chapter 3
Rapid and physiological effects of estradiol on Akt
The central hypothesis addressed in this chapter is that estradiol, via
membrane-initiated steroid signaling, rapidly activates the PI3K/Akt
pathway in the mouse hippocampal formation.  Furthermore, this estradiol
activation of Akt is associated with a rapid increase in PSD-95 protein
expression.
Three approaches were used to test this hypothesis. First, mice in the
proestrus, estrus and diestrus stages of the estrous cycle were assayed to
determine the effects of natural fluctuations of ovarian steroids on Akt
activation. Second, ovariectomized mice, sacrificed 6 hours after injection
with estradiol benzoate or vehicle, were assayed to determine the time
course of estradiol affects on Akt, and the relationship of Akt activation to
PSD-95 expression.  Finally, the requirement of ERs alpha and beta in Akt
activation was assessed using transgenic mice with targeted disruptions of
each receptor.  Akt activation was measured as phosphorylated Akt
immunoreactivity (pAkt-ir) and PSD-95 expression as PSD-95-ir in sections
through the dorsal hippocampal formation. This assay does not account for
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any change in total Akt protein after estradiol treatment, which was
considered unlikely given that estradiol does not affect Akt expression in
vitro (Akama and McEwen, 2003).  Because estradiol increases synaptic
protein expression throughout the mouse hippocampal formation (Li et al.,
2004), pAkt-ir and PSD-95-ir measurements were taken from several
hippocampal subregions: CA1 stratum radiatum, CA3 strata radiatum and
lucidum, and hilus of the dentate gyrus.
Akt activation fluctuates across the estrous cycle
To determine whether Akt activation fluctuates across the mouse
estrous cycle, pAkt-ir was assayed in the hippocampal formation of mice in
proestrus, estrus, and diestrus.  The pattern of pAkt-ir in the mouse
hippocampal formation by light microscopy (Figure 3.1A) was similar to
that in rats (Znamensky et al., 2003).  pAkt-ir localized to cell bodies and
processes of principle cells.  The densest labeling was seen in pyramidal cell
bodies and strata lucidum and lacunosum-moleculare.
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3.1 Hippocampal pAkt-ir fluctuates across the estrous cycle
(A) Images of peroxidase labeling of phosphorylated Akt in the dorsal
hippocampal formation of representative sections from one proestrus and
one estrus mouse.  pAkt-ir is darker throughout the hippocampus in
proestrus than in estrus.  (B) quantification of pAkt-IR in four hippocampal
subregions across the estrous cycle. pAkt-ir was significantly higher in
proestrus compared to estrus, and in diestrus compared to estrus.  *, p<0.05.
R.O.D., relative optical density. SR, stratum radiatum; SL, stratum lucidum;
DG HIL, hilus of the dentate gyrus. N = 4 for proestrus, 6 for estrus, and 11
for diestrus.
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pAkt-ir fluctuated across the estrous cycle, with the highest levels
during proestrus (Figure 3.1).  Consistent with a previous finding in rats
(Znamensky et al., 2003), pAkt-ir in the CA1 stratum radiatum was higher in
proestrus than estrus or diestrus.  However, one-way ANOVA showed only
a trend for an effect of cycle phase in this subregion (F(2, 17) = 2.702, p =
0.0957).  The effect of estrous cycle was much more pronounced in other
hippocampal subregions, which were not examined in the rat study.  There
was a significant effect of cycle phase in the CA3 stratum radiatum (F(2, 17)
= 4.919, p = 0.0206), CA3 stratum lucidum (F(2, 17) = 5.231, p = 0.0170),
and dentate hilus (F(2, 16) = 4.426, p = 0.0295),.  Post-hoc tests revealed
that pAkt-ir was significantly higher in proestrus than in estrus in all three of
these subregions (p<0.05 for all).  Additionally, pAkt-ir was significantly
higher in diestrus than in estrus in CA3 strata lucidum and radiatum (p<0.05
for both).  Thus Akt activation in the mouse hippocampal formation is
highest during proestrus, lowest during estrus, and these fluctuations are
most pronounced in the CA3 and dentate subregions.
To determine whether the fluctuation of pAkt-ir was specific to the
hippocampal formation rather than a global cerebral response to vascular or
metabolic changes across the cycle, pAkt-ir was measured in the
somatosensory cortex overlying the dorsal hippocampus in the same image
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from which hippocampal measurements were taken.  The relative optical
density of pAkt-ir in the somatosensory cortex, normalized to background
labeled in corpus callosum, was 24.5 +/- 2.2 in proestrus, 27.0 +/- 1.3 in
estrus, and 24.0 +/- 1.1 in diestrus, with no significant differences between
cycle phases.
Estradiol rapidly activates Akt and increases PSD-95 expression
The increase in pAkt-ir during proestrus suggests that the endogenous
increase in circulating estradiol during this cycle phase activates Akt.  To
assess directly whether estradiol rapidly activates Akt, ovariectomized mice
sacrifice 6 hours after injection with oil vehicle or 5 µg estradiol benzoate
were assayed for pAkt-ir in the dorsal hippocampal formation.  The time
point of 6 hours was chosen for its relevance to membrane-initiated
signaling. 5 µg estradiol benzoate, a slowly metabolized form of estradiol,
yields high physiologic levels of estradiol in mice sacrificed 24 hours after
injection (Russell Romeo, personal communication).
Estradiol increased pAkt-ir in every hippocampal subregion, but most










Figure 3.2  Estradiol increases hippocampal pAkt-ir and PSD-95-ir. 
pAkt-ir and PSD-95-ir were measured from several different hippocampal 
subregions in wild-type mice sacrificed six hours after injection with vehicle 
or estradiol benzoate. Estradiol significantly increased pAkt-ir and PSD-95-
ir in CA1 stratum radiatum.  *, p<0.05.  SR, stratum radiatum; SL, stratum 




























T-tests between vehicle and estradiol-treated groups in each hippocampal
subregion showed a significant effect of estradiol in CA1 stratum radiatum
(p = 0.0053) and a trend in CA3 stratum radiatum (p=0.0972).
Previous work using a neuronal cell line suggested that estradiol also
increases PSD-95 protein translation on a rapid time course that depends on
Akt activation.  If this is the case, 6 hours of estradiol treatment should also
increase PSD-95 expression.  Indeed, estradiol significantly increased PSD-
95-ir in the CA1 stratum radiatum (p = 0.0330; Figure 3.2B).
Rapid estradiol effect on Akt requires estrogen receptors
The above study demonstrated that 6 hours of estradiol treatment
increases pAkt-ir in the CA1 stratum radiatum.  To determine whether
estrogen receptor alpha or beta mediates these effects, the effect of estradiol
was assessed in mice with targeted disruptions of each receptor.  As in the
above study, ovariectomized mice were sacrificed 6 hours after vehicle or
estradiol injection.  pAkt-ir was measured in the CA1 stratum radiatum.
Estradiol did not affect pAkt-ir in ERKO or BERKO mice (Figure
3.3A).  Thus estradiol activation of Akt requires both ERs alpha and beta.
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Figure 3.3  Estradiol effects on pAkt depend on ERs.  pAkt-ir was
measured from the CA1 stratum radiatum of wild-type, ERKO, and BERKO
mice sacrificed 6 hours after injection with vehicle or estradiol benzoate.
Estradiol had no effect on pAkt-ir in ERKO of BERKO mice.  For
comparison, results from wild-type littermates are shown, where estradiol
significantly increased pAkt-ir. *, p<0.05.  N = 9 for wild-type mice, 6 for
ERKO vehicle, 5 for ERKO estradiol, and 7 for BERKO.
Discussion
The data presented in this chapter demonstrate that physiological and
pharmacological increases in circulating estradiol activate Akt in the mouse
hippocampal formation. Akt activation influences actin-remodeling and cell-
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survival pathways that may be important for estradiol effects on spine
synapse density and neuroprotection.  The entire hippocampal formation
exhibited this estradiol sensitivity, with the strongest effect of estrous cycle
in the CA3 and dentate, and the strongest effect of estradiol treatment in the
CA1.  The involvement of the entire hippocampal formation is consistent
with the finding that estradiol increases synaptic protein expression
throughout the mouse hippocampus (Li et al., 2004), but whether it
represents a species difference between mouse and rat in estradiol activation
of Akt remains to be seen.
The finding that pAkt-ir increased slightly (but significantly) during
diestrus relative to estrus was surprising and not previously reported in any
species.  This may be explained by considering the changing levels of
circulating progesterone in addition to estradiol in different estrous cycle
phases. Progestins can rapidly activate Akt in breast, endometrial,
leiomyoma, and cerebral cortical cells (Ballare et al., 2006; Kaur et al.,
2007; Hoekstra et al., 2009).  The increase in circulating progesterone during
diestrus (see Chapter 2) could therefore account for the increase in Akt
activation during this cycle stage.  Alternatively, increased pAkt-ir during
diestrus might represent a recovery of baseline Akt signaling after the
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precipitous drop in estradiol levels and concomitant decrease in Akt
signaling during estrus.
The increase in pAkt-ir six hours after estradiol injection is consistent
with membrane-initiated estradiol signaling.  After a six-hour treatment in
cultured neurons, estradiol activation of signaling pathways can still be
observed (Akama and McEwen, 2003; Yuen et al., 2004), while effects on
gene transcription are typically not yet seen (Gottfried-Blackmore et al.,
2007).  It is therefore reasonable to conclude that estradiol activates Akt by
signaling through membrane-associated ERs, at least in the CA1 stratum
radiatum. This is the first report of a rapid action of estradiol on Akt in vivo.
The same estradiol treatment also increased PSD-95 expression in the CA1
stratum radiatum, consistent with the finding that estradiol rapidly enhances
PSD-95 protein translation via Akt signaling in vitro (Akama and McEwen,
2003).
Extranuclear ERs alpha and beta can both mediate rapid membrane-
initiated estradiol signaling (Razandi et al., 1999), but the specific pathways
activated by each receptor have not been elucidated. In the current study,
knockout of each estrogen receptor, alpha and beta, eliminated the increase
in pAkt-ir after six hours of estradiol treatment in ovariectomized mice.
This suggests that estradiol activates Akt by a mechanism involving both
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ERs.  It is consistent with previous studies in the NG108-15 cell line from
the McEwen laboratory, which showed that both ERs alpha and beta can
mediate estradiol activation of actin remodeling pathways downstream of
Akt (Yuen, 2006).  The importance of ER alpha for estradiol activation of
Akt was not surprising.  ER alpha binds in vitro to the p85 regulatory
subunit of PI3K in rat primary cortical neurons (Mannella and Brinton,
2006), and could therefore participate in Akt activation through direct
interaction with its upstream activator. ER beta does not interact with p85 in
vitro (Simoncini et al., 2000), but aside from this its role in Akt activation
has not been investigated.  The finding that ER beta knockout blocks Akt
activation suggests that ER beta has a hitherto unrecognized role in estradiol
activation of Akt.
In sum, both physiologic and pharmacologic increases in estradiol
activate Akt in the mouse hippocampal formation.  Estradiol activation of
Akt is rapid, correlates with an increase in PSD-95 expression, and requires
ERs alpha and beta.
50
Chapter 4
Physiological effect of estradiol on TrkB activation
The TrkB ligand, BDNF, has attracted much attention for its role in
mood and cognition. BDNF and estradiol target similar pathways and
proteins in the hippocampal formation, including the PI3K/Akt pathway and
PSD-95 protein (Mizuno et al., 2003b; Jia et al., 2008; Luikart et al., 2008).
In addition, estradiol increases BDNF expression in the rat hippocampus
(Gibbs, 1998, 1999; Scharfman et al., 2003; Scharfman et al., 2007). I
therefore hypothesized that BDNF would be an important player in estradiol
actions in the mouse hippocampal formation.
The central hypothesis addressed in this chapter is that increased
circulating estradiol leads to increased BDNF expression and release,
thereby enhancing activity of the BDNF receptor, TrkB. Two approaches
were used to test this hypothesis.  First, mice in the proestrus, estrus and
diestrus stages of the estrous cycle were assayed to determine the effects of
natural fluctuations of ovarian steroids on TrkB activation.  Second,
ovariectomized mice sacrificed 6 hours or 48 hours after vehicle or estradiol
benzoate injection were assayed to determine the time course of estradiol
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effects on BDNF expression and TrkB activation. TrkB activation was
measured as pTrkB-ir. Because this assay does not account for changes in
TrkB expression, TrkB mRNA was measured using in situ hybridization to
assess any changes in TrkB expression across the estrous cycle.
TrkB activation fluctuates across the estrous cycle
By light microscopy, pTrkB-ir localized to cell bodies and neuropil
throughout the hippocampal formation (Figure 4.1A). In addition, pTrkB
strongly labeled cells in the subgranular zone (SGZ) of the dentate gyrus, an
area that gives rise to newly born neurons that integrate into hippocampal
circuits (Doetsch and Hen, 2005).  Finally, pTrkB labeled glial cells, which
could be identified by the distinctive morphology of their processes within
the neuropil.
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Figure 4.1 pTrkB-ir fluctuates across the estrous cycle (A) Images of
peroxidase labeling of pTrkB in the dorsal hippocampal formation of
representative sections from one proestrus and one diestrus mouse.  pTrkB-ir
is darker throughout the hippocampal formation in proestrus than in diestrus.
(B) quantification of pTrkB-ir in five hippocampal subregions. pTrkB-ir was
significantly higher in proestrus than estrus and diestrus. . SR, stratum
radiatum; SL, stratum lucidum; DG HIL, hilus of the dentate gyrus; SGZ,
subgranular zone. *, p<0.05. N = 4 for proestrus, 6 for estrus, and 11 for
diestrus.
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pTrkB-ir was highest during proestrus in all hippocampal subregions
(Figure 4.1B).  One-way ANOVA showed a significant effect of cycle phase
in all hippocampal subregions: CA1 stratum radiatum (F(2, 17) = 7.378, p =
0.0041), CA3 stratum lucidum (F(2, 17) = 5.494, p = 0.0144), CA3 stratum
radiatum (F(2, 17) = 5.559, p = 0.139), dentate hilus (F(2, 16) = 10.21, p =
0.0014), and subgranular zone (F(2 16) = 6.377, p = 0.0092).  Post-hoc tests
revealed that pTrkB-ir was significantly higher in proestrus than in estrus or
diestrus in all subregions (p < 0.05 for all).
To determine whether the fluctuation of pTrkB-ir was specific to the
hippocampal formation, pTrkB-ir was measured in the sensory cortex
overlying the dorsal hippocampus in the same images from which
hippocampal measurements were taken.  The relative optical density of
pTrkB-ir in the cortex was 22.6 +/- 3.4 in proestrus, 23.6 +/- 2.1 in estrus,
and 20.0 +/- 1.9 in diestrus, with no significant differences between cycle
phases.
Hippocampal TrkB mRNA does not fluctuate across the estrous cycle
The proestrus increase in TrkB activation is presumably caused by an
increase in BDNF expression during proestrus, as has been demonstrated in
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rats (for mouse, see Chapter 6).  However, it is also possible that the
expression of TrkB itself fluctuates across the estrous cycle.  Although no
studies have examined the effects of estradiol on TrkB expression in vivo,
estradiol increases TrkB expression in hypothalamic neurons in vitro (Carrer
et al., 2003).  To test whether natural fluctuations in ovarian steroids affect
TrkB expression in female mice, TrkB mRNA was measured using in situ
hybridization on tissue sections from mice in proestrus or diestrus (Figure
4.2).  Optical density measurements were taken from the CA1 pyramidal cell
layer and the ventromedial hypothalamus (VMH).  TrkB mRNA increased
significantly during proestrus in the VMH (p = 0.0182), but not the CA1 (p
= 0.3503).  This suggests that circulating estradiol increases TrkB expression
in the hypothalamus, but not in the hippocampus.
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Figure 4.2 Hippocampal TrkB mRNA does not fluctuate across the
cycle. Optical density of TrkB mRNA from in situ hybridization films was
measured from the CA1 pyramidal cell layer of the hippocampus and the
ventromedial hypothalamus and normalized to background density.  TrkB
mRNA was significantly higher in proestrus than diestrus in hypothalamus,
but not hippocampus. . SR, stratum radiatum; SL, stratum lucidum; DG HIL,
hilus of the dentate gyrus; VMH, ventromedial hypothalamus; R.O.D.,
relative optical density. * p<0.05. N = 5.
Estradiol increases BDNF expression and TrkB activation
Although estradiol most likely increases TrkB activation by increasing
BDNF gene transcription, more rapid mechanisms could be involved.  ERs
are known to couple to several other growth factor receptors (such as the
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IGF-1 receptor), increasing their activation (Mendez et al., 2006).  In
addition, the glucocorticoid family of steroid hormones has been shown to
activate TrkB through a glucocorticoid receptor-dependent, BDNF-
independent mechanism, suggesting that rapid ER-dependent TrkB
activation could also occur (Jeanneteau et al., 2008).  To determine whether
estradiol rapidly activates TrkB independent of BDNF expression, BDNF
mRNA and pTrkB-ir was measured in the hippocampal formation of
ovariectomized mice sacrificed 6 hours after estradiol benzoate or vehicle
injection (Figure 4.3).  Estradiol had no effect on BDNF mRNA or pTrkB-ir
at this time point, suggesting that the effect of estradiol on TrkB activation
occurs over a longer treatment time and depends on an increase in BDNF
expression.   To test this hypothesis, BDNF mRNA and pTrkB-ir were
measured in mice sacrificed after two daily injections of estradiol benzoate
or vehicle, for a total treatment time of 48 hours (Figure 4.4).  BDNF mRNA
was assayed using in situ hybridization with an oligonucleotide probe
specific for the coding region of the BDNF gene.  In the hippocampus,
BDNF expression is strongest in the dentate granule cell and CA3 pyramidal
cell layers; for this study, optical density was measured from the CA3
pyramidal cell layer.
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Figure 4.3 Six hours of estradiol treatment does not alter BDNF/TrkB
signaling (A) BDNF mRNA was measured in the CA3 cell layer from mice
sacrificed 6 hours after vehicle or estradiol benzoate injection.  Estradiol had
no effect on BDNF mRNA. (B) pTrkB-ir was measured from several
different hippocampal subregions in the same mice.  Estradiol had no effect
on pTrkB-ir in any hippocampal subregion. SR, stratum radiatum; SL,
stratum lucidum; DG HIL, hilus of the dentate gyrus. N = 9.
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Figure 4.4 Forty-eight hours of estradiol treatment increases
BDNF/TrkB signaling. (A) BDNF mRNA was measured in the CA3
pyramidal cell layer from wild-type mice sacrificed after two daily injections
of estradiol benzoate, for a total treatment time of 48 hours.  Estradiol
significantly increased BDNF mRNA.  (B) pTrkB-ir was measured from
several different hippocampal subregions in the same mice.  Estradiol
significantly increased pTrkB-ir in the CA3 stratum radiatum.  SR, stratum
radiatum; SL, stratum lucidum; DG HIL, hilus of the dentate gyrus. R.O.D.,
relative optical density.  *p<0.05. N = 8 (vehicle), 9 (estradiol benzoate).
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Forty-eight hours of estradiol treatment significantly increased BDNF
mRNA in the CA3 pyramidal cell layer (p = 0.0375) and pTrkB-ir in the
CA3 stratum radiatum (p = 0.02).
Previous work in slices from rat hippocampus suggested that estradiol
increases PSD-95 expression in the CA3 subregion, and that this effect
depends on TrkB receptors (Sato et al., 2007).  If this mechanism operates in
the mouse hippocampus, then 48 hours of estradiol treatment should increase
PSD-95 expression in concert with TrkB activation in the CA3 stratum
radiatum.  To test this hypothesis, PSD-95-ir was assayed in the dorsal
hippocampal formation of mice treated for 48 hours with vehicle or estradiol
benzoate (Figure 4.5).  Estradiol significantly increased PSD-95-ir only in
the CA3 stratum radiatum (p = 0.0152).
In sum, estradiol does not rapidly activate TrkB, but rather increases
TrkB relatively slowly in concert with an increase in BDNF expression.  The
increase in TrkB activation in the CA3 stratum radiatum after estradiol
treatment correlates with an increase in PSD-95 protein expression.
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4.5 Forty-eight hours of estradiol treatment increases PSD-95
immunoreactivity. PSD-95-ir was measured in several different
hippocampal subregions from wild-type mice sacrificed after two daily
injections of estradiol benzoate, for a total treatment time of 48 hours.
Estradiol significantly increased PSD-95-ir in the CA3 stratum radiatum. .
SR, stratum radiatum; DG HIL, hilus of the dentate gyrus. *p<0.05. N = 8
(vehicle), 9 (estradiol benzoate).
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Estradiol induction of BDNF requires ER beta
To determine whether estrogen receptor alpha or beta mediates
estradiol induction of BDNF, the effect of estradiol on BDNF expression
was assessed in mice with targeted disruptions of each receptor.  As in the
above study, ovariectomized mice were sacrificed after two daily injections
of vehicle or estradiol benzoate, for a total treatment time of 48 hours.
BDNF mRNA was assayed using in situ hybridization and measured in the
CA3 pyramidal cell layer (Figure 4.6).
Estradiol significantly increased BDNF mRNA in ERKO mice (p =
0.0352), similar to its effect in wild-type mice.  In contrast, estradiol had no
effect on BDNF mRNA in BERKO mice.  Thus estradiol induction of
BDNF expression requires ER beta, but not ER alpha.
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Figure 4.6 Estradiol induction of BDNF depends on estrogen receptor
beta.  BDNF mRNA was assayed using in situ hybridization and measured
from the CA3 pyramidal cell layer of wild-type, ERKO, and BERKO mice
sacrificed 48 hours after injection with vehicle or estradiol benzoate.
Estradiol significantly increased BDNF mRNA in ERKO, but not BERKO,
mice.  For comparison, results from wild-type littermates are shown, where
estradiol significantly increased BDNF mRNA. *, p<0.05. N = 8 for wild-
type vehicle, 9 for wild-type estradiol benzoate, 7 for ERKO vehicle, and 6
for the remaining groups.
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Discussion
The data presented in this chapter demonstrate that physiologic and
pharmacologic increases in circulating estradiol increase TrkB activation.
This effect of estradiol is most likely mediated by increased BDNF
expression, as estradiol increased BDNF but not TrkB mRNA.  The
downstream effects of TrkB on local synaptic signaling and hippocampal
gene expression likely contribute to estradiol enhancement of synaptic
plasticity.
In contrast to the hippocampus, TrkB mRNA did fluctuate across the
estrous cycle in the ventromedial hypothalamus, increasing dramatically
during proestrus.  Thus estradiol has distinct effects in different brain areas.
There are many possible explanations for this difference, including the
estrogen receptors and cofactors expressed by hypothalamic and
hippocampal neurons, the location of the receptors (e.g. nuclear or
extranuclear), and level of exposure to circulating factors including steroids.
That a hormone such as estradiol may act so differently in two brain areas
highlights the importance of directly investigating its specific effects in the
hippocampal formation.
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Although estradiol may affect BDNF expression via membrane-
initiated signaling, this mechanism still requires new BDNF gene
transcription, which likely requires at least 12 hours of estradiol exposure
(see Chapter 1).  Consistent with this idea, 6 hours of estradiol treatment did
not significantly alter BDNF mRNA or pTrkB-ir in ovariectomized mice,
but 48 hours of estradiol treatment increased both BDNF mRNA and TrkB
activation in the CA3 stratum radiatum. The same estradiol treatment also
increased PSD-95 expression in the CA3 stratum radiatum.  This correlation
suggests that BDNF signaling through TrkB may be involved in estradiol
induction of PSD-95 in the CA3 of the mouse hippocampus, as was
previously found in rat hippocampal slices in vitro (Sato et al., 2007).  The
limitation of this increase in pTrkB-ir and PSD-95-ir to the CA3 contrasts
with the hippocampus-wide increase in pTrkB-ir during proestrus.  As with
Akt in Chapter 4, the involvement of the whole hippocampal formation
during proestrus may be related to the timing of estradiol exposure in these
different models.
This is the first study to investigate the contribution of estrogen
receptors to estradiol effects on BDNF expression.  The estradiol-mediated
induction of BDNF expression was eliminated in BERKO mice missing the
ER beta, suggesting that ER beta mediates this effect. In contrast, the ERKO
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mice missing the ER alpha showed an exaggerated estradiol-mediated
induction of BDNF.  This further suggests that ERs alpha and beta have
opposing effects on BDNF expression, with ER alpha mitigating the
enhancing effect of ER beta on BDNF expression.  Opposing transcriptional
effects of ERs alpha and beta on specific genes have been described in
several different cell types (Matthews and Gustafsson, 2003).  This
opposition could serve as a homeostatic mechanism to dampen or control
hormone actions – in the hippocampus, too much BDNF could increase
neuronal excitability to toxic levels.
In sum, both physiologic and pharmacologic increases in circulating
estradiol increased BDNF expression and TrkB activation in the dorsal
hippocampal formation of female mice.  Increased BDNF expression and
TrkB activation in the CA3 subregion correlated with an increase in PSD-95
expression.  Estradiol induction of BDNF required estrogen receptor beta.
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Chapter 5
Ultrastructural distribution of pTrkB depends on sex and cycle stage
Up to this point, this thesis has addressed widespread estradiol effects
on signaling molecule activation and protein expression in the hippocampal
formation that can be observed at the light microscopic level.  The ultimate
goal of identifying these estradiol effects is to understand the mechanism of
estradiol enhancement of synaptic plasticity.  Although widespread changes
are likely important for this process, synaptic plasticity involves activity-
dependent changes to specific hippocampal synapses.  Therefore, if estradiol
enhances synaptic plasticity in the hippocampus, then it must facilitate these
types of synapse-specific changes, which are unobservable by conventional
light microscopy.
The TrkB receptor could be important for communicating the
widespread effects of estradiol in the hippocampus to specific synapses.
Increased BDNF release at active synapses may serve to “tag” these
individual synapses for modification via TrkB activation (Frey and Morris,
1998; Boulanger and Poo, 1999; Nagappan and Lu, 2005; Reymann and
Frey, 2007).  By increasing BDNF expression, estradiol could facilitate the
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ability of an active synapse to release enough BDNF to tag its synapse.  In
this way, the hippocampus would experience a targeted increase in TrkB
activation at locations of activity-dependent BDNF secretion during periods
of high circulating estradiol.
By light microscopy, it is impossible to determine the precise location
of the TrkB receptors that “see” increased BDNF when circulating estradiol
increases.  Investigation of this hypothesis relies on the precise localization
of activated TrkB under conditions of higher and lower circulating estradiol.
TrkB is expressed almost ubiquitously in the brain (Yan et al., 1997), yet the
precise sites of TrkB activation in the intact organism are still unknown.
The best way to identify these sites in the brain is with electron microscopy.
In addition to its importance for investigating estradiol actions, identification
of the cell types and subcellular locations of activated TrkB under different
conditions will provide crucial information about experience-dependent
plasticity in general.
For this experiment, I collaborated with Dr. Teresa Milner in her
laboratory at Weill Cornell medical college.   We conducted
immunocytochemistry and performed a quantitative analysis of the sites of
pTrkB-ir in the mouse hippocampal formation using electron microscopy.
To assess changes in the distribution of pTrkB under conditions of higher
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and lower estradiol, the distribution of pTrkB-ir was compared among
different phases of the estrous cycle and also between sexes.  By comparing
proestrus females, where pTrkB-ir was enhanced overall by light
microscopy, to lower-estradiol females and males, we uncovered shifts in
the distribution of pTrkB-ir that will be important to the mechanism of
estradiol and BDNF-dependent plasticity.
Light microscopic immunolocalization of pTrkB
In sections from mice perfused with acrolein in preparation for
electron microscopy, the light microscopic localization of pTrkB-ir was
consistent with the previously described pattern from mice perfused with
paraformaldehyde (Figure 5.1A; see Chapter 4). Pre-adsorption of the
primary antisera with pTrkB blocking peptide eliminated all labeling (Figure
5.1B).
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Figure 5.1 Light microscopic localization of pTrkB. (A) By light
microscopy, the pTrkB antiserum labels neuronal cell bodies and neuropil in
the CA1, CA3 and dentate gyrus in acrolein- and paraformaldehyde-fixed
tissue.  (B) Pre-adsorption with pTrkB blocking peptide completely
eliminates all labeling.
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Presynaptic profiles contain the most abundant pTrkB-ir
To determine the distribution of pTrkB in neurons and glia, pTrkB-ir
was identified using electron microscopy in the dorsal hippocampal
formation of 9 cycled female and 3 male mice.  Profiles were counted from
12 different hippocampal laminae lacking principal cell perikarya in CA1,
CA3, and dentate, for a total area of 2,646 µm2 per mouse (Table 6.1).  An
average of 388.3 +/- 19.03 labeled profiles were counted for each animal,
with no difference between estrous cycle stages or sexes.  Labeled profiles
were identified as dendrites, dendritic spines, axons, axon terminals, or glia.
Less than 1% of labeled profiles were unidentifiable, and these unknowns
were not included in the analyses.
The majority of pTrkB-ir was in presynaptic profiles regardless of sex
or estrous cycle stage, with 36.0 +/- 1.3% in axons and 17.3 +/- 0.6% in
axon terminals.  Postsynaptic profiles contained one quarter of the pTrkB-ir,
with 16.7 +/- 0.9% in dendrites and 10.7 +/- 0.7% in dendritic spines. Glial
profiles accounted for one fifth of the total pTrkB-ir, 19.3 +/- 0.9%.
71
Table 5.1 Distribution of pTrkB-ir in the hippocampal formation of
cycling female and male mice
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Axons and axon terminals, including mossy fibers, contain pTrkB-ir
Throughout the hippocampal formation, pTrkB-ir was affiliated with
the plasma membrane of small unmyelinated axons (Figure 5.2A).
Occasionally, larger myelinated axons contained pTrkB-ir, usually affiliated
with endomembranes or mitochondria (Fig. 5.2B).  Diffuse pTrkB-ir filled
the cytoplasm of some small-caliber axons (Figure 5.2B). pTrkB-ir also was
localized using silver-intensified gold particles (SIG), allowing more
discrete localization of labeling.  With this method, pTrkB SIG-ir was on or
near the axon plasma membrane (Figure 5.2C).
In axon terminals, pTrkB-ir was in clusters most often affiliated with
small synaptic vesicles opposite the synaptic contact (Figure 5.3A).  Discrete
patches of pTrkB-ir localized to small synaptic vesicles of large terminals
with morphological characteristics of mossy fibers in the CA3 stratum
lucidum (Figure 5.3B).  Labeled mossy fiber terminals often contained
several patches of immunolabeling.  Occasionally, these labeled terminals
contacted pTrkB-labeled spines (Figure 5.3B).  SIG labeling revealed
pTrkB-ir adjacent to the presynaptic contact, or on mitochondria inside the










Figure 5.2 pTrkB-ir is most prominent in axons throughout the 
hippocampal formation. (A) In the CA1 stratum radiatum, pTrkB-ir 
(arrowheads) is found in clusters within axonal profiles (a).  (B) In the 
stratum lucidum, pTrkB-ir is found in axon bundles most likely belonging to 
the mossy fiber pathway, and in myelinated axons (ma). (C) In CA1 stratum 
radiatum, SIG pTrkB-ir (arrowheads) is found in axons near the plasma 


























Figure 5.3 pTrkB-ir is found in axon terminals throughout the 
hippocampal formation.  (A) In the CA1 stratum radiatum, pTrkB-ir 
(arrowheads) clusters among small synaptic vesicles in axon terminals (t).  
One of the pTrkB-labeled terminals (lower left) forms an asymmetric 
synapse (arrow) with the shaft of an unlabeled dendrite (d).  (B) A mossy 
fiber terminal (mt) in the CA3 stratum lucidum contains pTrkB-ir associated 
with small synaptic vesicles and mitochondria.  The pTrkB-labeled mossy 
fiber terminal contacts a dendritic spine (sp) containing pTrkB-ir.  (C) In the 
CA1 stratum radiatum, SIG pTrkB-ir (arrowheads) is in axon terminals, on 
the membrane of a mitochondrion and affiliated with small synaptic vesicles 
















To confirm the localization of pTrkB-ir to mossy fibers and terminals,
a few sections were dually labeled for pTrkB and the opioid peptide
dynorphin, which is exclusively found in mossy fibers in the stratum
lucidum (Drake et al., 2007).  Indeed, dynorphin-immunoreactive axon
bundles and mossy fiber terminals also contained pTrkB-ir (Figure 5.4),










Figure 5.4 pTrkB-ir colocalizes with dynorphin in the mossy fiber 
pathway. (A) pTrkB-ir (peroxidase; arrowhead) and dynorphin-ir (SIG, 
black particles; arrow) localizes to the same axon bundle (ab) in the CA3 
stratum lucidum.  (B and C) Higher magnification shows dynorphin-ir and 
pTrkB-ir affiliated with vesicles in the axon (a).  (D) A large mossy fiber 
terminal (mt) with dynorphin-ir (SIG, arrows) shows a cluster of pTrkB-ir 





























Dendrites and dendritic spines contain pTrkB-ir
In dendrites, both labeling methods showed pTrkB-ir affiliated with
the plasma membrane and endomembranes (Figure 5.5).  Although more
pTrkB-ir localized to axons than dendrites, a single dendrite often contained
several patches of pTrkB-ir.  In contrast to the pTrkB-ir contained in axon
terminals, which was usually affiliated with vesicles opposite the synaptic
contact, pTrkB-ir in dendritic spines was often affiliated with the spine
apparatus adjacent to the synaptic contact (Figure 5.6). Occasionally, a
labeled dendritic spine contacted a labeled axon terminal (Figure 5.6 A and
B).
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Figure 5.5 pTrkB-ir is found in dendritic shafts throughout the hippocampal
formation.  (A) In the CA1 stratum radiatum, clusters of pTrkB-ir
(arrowheads) are found near the plasma membrane in dendritic shafts (d).
(B and C) Immunogold labeling reveals pTrkB-ir (arrowheads) on the
plasma membrane and affiliated with endomembranes (em, arrow) within











Figure 5.6 pTrkB-ir is found in dendritic spines throughout the 
hippocampal formation.  (A) In the CA1 stratum radiatum, a dendritic 
spine (sp) containing pTrkB-ir (arrowheads) is contacted by a labeled axon 
terminal (t).  (B) In the CA3 stratum lucidum, the same unlabeled mossy 
fiber terminal (mt) contacts two separate pTrkB-labeled spines. (C) SIG 
labeling shows pTrkB-ir (arrowheads) clustered next to the postsynaptic 


























Glial profiles contain pTrkB-ir
In addition to the neuronal pTrkB described above, many glial profiles
contained pTrkB labeling.  Diffuse pTrkB-ir was seen in glial profiles from
sections labeled using the ABC-peroxidase method (Figure 5.7A).  SIG
pTrkB-ir was primarily on the plasma membrane of glia (Figure 5.7B).
With these methods, it was not possible to distinguish among different types
of glia containing pTrkB-ir.
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5.7 pTrkB-ir is found in glial profiles throughout the hippocampal
formation. (A) In the CA1 stratum radiatum, diffuse pTrkB-ir (arrowhead)
is found in glial profiles (g).  (B) SIG pTrkB-ir (arrowheads) is affiliated
with the plasma membrane of a glial profile.  Scale bars, 0.5 µm.
Few synaptic profiles contain pTrkB-ir
To determine the proportion of synaptic contacts containing pTrkB
labeling, unlabeled axon terminals and dendritic spines in the distal CA1
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stratum radiatum were counted.  In this lamina, axon terminals were present
at a density of 0.59 per µm2, and dendritic spines at 0.47 per µm2.  The
greater density of terminals reflects the presence of some axon terminals
making asymmetric contacts with dendritic shafts, and the relative ease of
identifying terminals outside the plane of the synaptic contact.  pTrkB
immunoreactivity was discerned in only 6.1 +/- 0.7% of axon terminals and
4.7 +/- 0.8% of dendritic spines.  This suggests that at a given time, TrkB is
activated in only a very small number of the total axon terminals and
dendritic spines in the distal CA1 stratum radiatum of the mouse.
pTrkB-ir in axons increases in proestrus
Chapter 5 of this thesis demonstrated that pTrkB-ir increases during
proestrus relative to estrus and diestrus in the mouse hippocampal formation.
To determine whether a shift in the distribution of pTrkB-ir accompanies
this proestrus increase in total pTrkB-ir, the distribution of pTrkB-ir in
proestrus females was compared with its distribution in estrus and diestrus
females as well as males.
In proestrus animals, the relative number of pTrkB-labeled profiles
increased in the CA1 subregion. Relative to the number of labeled profiles in
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the entire hippocampal formation, there was more pTrkB-ir in the CA1 of
proestrus females than in other groups of females or males (44.9 +/- 2.1%;
Table 5.1). This was evident statistically as an overall effect of cycle phase
on profile percent in the CA1 region (F(3, 40) = 3.047, p = .0396). The most
striking difference was between sexes: proestrus females showed 34%
increase in pTrkB-ir in the CA1 relative to males.  In particular, post-hoc
tests revealed that proestrus females had significantly more pTrkB-labeled
axons in CA1 than males (p<0.05).  Therefore, on top of the widespread
increase in pTrkB-ir in the hippocampal formation during proestrus, axons in
the CA1 may show particularly robust TrkB phosphorylation when
circulating estradiol levels increase.
The increase in pTrkB-ir in the CA1 during proestrus may occur
throughout this subregion, or in specific hippocampal laminae.  After
comparing the distribution of pTrkB-ir in each of the CA1 laminae, we
found that the increase in labeled axons during proestrus occurred
exclusively in the distal stratum radiatum of the CA1 (Figure 5.8).  Two-way
ANOVA revealed an overall effect of cycle/sex (F(3, 40) = 3.606, p =
0.0214).  Post-hoc tests showed that pTrkB-labeled axons were significantly
increased in proestrus females relative to estrus and diestrus females and
males (p<0.05 for all).  This indicates that the overall increase in pTrkB-ir in
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the CA1 during proestrus resulted primarily from an increase in pTrkB-
labeled axons in the distal CA1 stratum radiatum.  Proestrus females also
had more pTrkB-labeled dendritic spines and axon terminals in CA1 stratum
radiatum than other females or males, but these differences were not
statistically significant in post-hoc analyses.
5.8 Axonal pTrkB-ir in the distal CA1 stratum radiatum is affected by
estrous cycle stage.  The number of profiles in each cellular compartment
was expressed as a percentage of the counted profiles counted in all sampled
hippocampal areas.  Females in the proestrus phase of the estrous cycle had
significantly more pTrkB-labeled axons than estrus and diestrus females and
males.  *, p<0.05. N = 3.
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Shifts in the distribution of pTrkB-ir also may occur within each
hippocampal subregion, without any change in the overall percentage of
pTrkB-labeled profiles in that region. Analysis of the distribution of pTrkB-
labeled profiles within each hippocampal subregion revealed this type of
redistribution in the CA3 stratum lucidum (Figure 5.9).
5.9 Axonal pTrkB-ir in the CA3 stratum lucidum is affected by estrous
cycle stage and sex.  The number of profiles in each cellular compartment
was expressed as a percentage of the counted profiles in the CA3 region.
Females in the proestrus phase of the estrous cycle had significantly more
pTrkB-labeled axons than estrus and diestrus females and males.  Male mice
had significantly more pTrkB-labeled axon terminals than proestrus and
estrus females. *, p<0.05. N = 3.
90
Two-way ANOVA revealed an interaction between cycle/sex and profile
type (F(12, 40) = 2.254, p = 0.0272). Post-hoc tests showed that, similar to
the findings in CA1 stratum radiatum, proestrus females had more pTrkB-
labeled axons in stratum lucidum than estrus and diestrus females males
(p<0.05 for all).  In contrast, males had more pTrkB-labeled axon terminals
than proestrus and estrus females (p<0.05), but not diestrus females.  This
indicates that when circulating estradiol increases during proestrus, the
proportion of pTrkB-ir decreases in axons and increases in axon terminals.
Discussion
This is the first study to precisely localize activated TrkB in the mouse
hippocampal formation.  The extensive quantitative analysis is relevant not
only to estradiol effects on TrkB, most pertinent to this document, but also
for its general relevance to TrkB signaling and synaptic plasticity.  This
section will therefore discuss the findings with these specific and general
implications in mind.
Previous immunocytochemical localization of TrkB in the rat
hippocampal formation, performed by the Milner lab using electron
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microscopy, showed extensive labeling of axon initial segments (Drake et
al., 1999).  In that study, the authors suggested that this labeling indicated
extensive trafficking of TrkB to axons.  The current study extends that
finding, showing that the majority of activated TrkB, measured as pTrkB-ir,
is in axons and axon terminals in the mouse hippocampal formation.
Furthermore, this abundant presynaptic pTrkB was sensitive to natural
fluctuations of ovarian steroids across the estrous cycle.
Methodological considerations
The pTrkB antibody used in these studies was tested for specificity
using several methods (see Chapter 8), but future studies should confirm this
in sections from a TrkB conditional knockout mouse.  The antibody does not
recognize the pTrkA neurotrophin receptor, but does recognize the pTrkC
receptor in Western Blots from HEK293 cells (Moses Chao, personal
communication).  This cross-reactivity is unlikely to confound the present
immunocytochemistry studies, as we saw no colocalization between pTrkB
and TrkC antibodies in fluorescent immunocytochemistry on hippocampal
sections (Joanna Spencer, unpublished observations).
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pTrkB is positioned to locally regulate synaptic transmission and
neurite growth
In vitro, TrkB modulates pre- and postsynaptic properties, including
synaptic vesicle dynamics, neurotransmitter release, calcium influx, actin
dynamics, and dendritic spine remodeling (Ji et al., 2005; Gomes et al.,
2006; Magby et al., 2006; Rex et al., 2007).  The localization of pTrkB-ir to
both axon terminals and dendritic spines in the current study suggests that
TrkB may indeed locally modulate synaptic function in the intact mouse
hippocampus.  In most cases, the pTrkB-ir in spines and terminals was not
affiliated with the plasma membrane.  This suggests that the rapid
endocytosis of activated TrkB that has been described in cultured neurons
may also occur in vivo (Du et al., 2003). In spines, pTrkB-ir was often
adjacent to the synaptic density, positioning the receptor for local
degradation or recycling back to the plasma membrane (Chen et al., 2005;
Zheng et al., 2008).  In contrast, in axon terminals, pTrkB-ir was often
affiliated with small synaptic vesicles distal to the synaptic contact,
suggesting that this internalized pTrkB may be in transit down the axon.
Such retrograde transport of pTrkB has been previously described, and may
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function to communicate TrkB signaling from the synapse to the cell body
(Bhattacharyya et al., 1997; Watson et al., 1999).
Despite the important role ascribed to TrkB activation at the synapse,
less than 10% of the terminals and spines in the CA1 stratum radiatum
contained pTrkB-ir. The pre-embedding immunocytochemical method used
to localize pTrkB in this study may slightly underestimate the total amount
of pTrkB contained in the tissue (Milner et al., 2005).  Still, this finding is
striking, as TrkB itself is most likely present in every glutamatergic
hippocampal neuron.  The specific complement of synapses containing
activated TrkB at any given time may be meaningful for the encoding or
retrieval of information, perhaps participating in the “tagging” of individual
synapses for sustained potentiation (Frey and Morris, 1998; Boulanger and
Poo, 1999; Nagappan and Lu, 2005; Reymann and Frey, 2007).
In addition to its synaptic effects, TrkB may locally regulate axonal
and dendritic arborization (Alsina et al., 2001; Horch and Katz, 2002; Horch,
2004).  Indeed, pTrkB-ir was often affiliated with the plasma membrane in
axons and dendrites, suggesting local activation of TrkB in these neuronal
processes.
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pTrkB is positioned to regulate glial cell function
The role of TrkB in glial cell function in the adult has received very
little attention.  It is widely believed that glia express only the truncated
TrkB isoform lacking the intracellular catalytic domain (Alderson et al.,
2000; Rose et al., 2003; Ohira et al., 2005; Ohira et al., 2007).  However,
one study found that cortical glia in culture express a small amount of
functional full-length TrkB (Roback et al., 1995).  The current study found
that glial profiles contained one fifth of all pTrkB-ir, using an antibody that
recognizes only the full-length TrkB. This suggests that not only do glial
cells in the adult hippocampal formation express the full-length TrkB, but
that this TrkB can be activated and may be an important aspect of
neurotrophin functions in vivo.
Presynaptic pTrkB is implicated in estrous cycle fluctuation of BDNF
signaling
In Chapter 4, I demonstrated that pTrkB-ir increases in the mouse
hippocampal formation during proestrus.  The current study revealed
increased pTrkB-ir in axons likely contributed to these changes in two
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specific subregions, the CA1 stratum radiatum and CA3 stratum lucidum.
The anatomical specificity of this finding is notable, as these two
hippocampal laminae contain crucial synaptic contacts for hippocampal
function and synaptic plasticity. Mossy fiber synapses on CA3 pyramidal
cell dendrites in stratum lucidum are critical for spatial learning in mice
(Stupien et al., 2003; Florian and Roullet, 2004; Gartner et al., 2006; Kesner,
2007). Schaffer collateral synapses of CA3 axons on CA1 pyramidal cell
dendrites, in CA1 stratum radiatum, are the most well characterized site of
hippocampal LTP (Kerchner and Nicoll, 2008).  TrkB activation at these
synapses is crucial for LTP and hippocampal-dependent associative learning
(Gruart et al., 2007).  Given the importance of these two laminae for
hippocampal function, increased TrkB activity in these areas likely
contributes to the increased hippocampal excitability and plasticity during
proestrus (Warren et al., 1995; Scharfman et al., 2003).
The proestrus increase in axonal pTrkB-ir, as opposed to pTrkB-ir in
other cell compartments, has several possible implications.  Increased axonal
TrkB activation could increase arborization to affect synaptic plasticity
indirectly through the availability of presynaptic contacts.  Although an
effect of estradiol on hippocampal axons has not been reported, estradiol
increases axonal growth of cultured hypothalamic neurons through a TrkB-
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dependent mechanism (Carrer et al., 2003; Brito et al., 2004).  Furthermore,
in rat hippocampal slices, estradiol does indeed increase the number of
presynaptic sites (Sato et al., 2007).
Alternatively, increased axonal pTrkB-ir in proestrus could reflect
increased retrograde transport of pTrkB, perhaps due to increased TrkB
activation at axon terminals.  Increased retrograde transport of pTrkB might
decrease pTrkB-ir in axon terminals, as occurred in CA3 stratum lucidum
during proestrus.  A role for presynaptic TrkB in synaptic potentiation was
first described in studies of the developing neuromuscular junction (Lohof et
al., 1993; Stoop and Poo, 1996).  These findings have since been extended to
hippocampal neurons (Kang and Schuman, 1995; Pozzo-Miller et al., 1999;
Xu et al., 2000; Tyler and Pozzo-Miller, 2001; Bamji et al., 2006; Madara
and Levine, 2008).  The current finding that presynaptic pTrkB-ir increased
during proestrus is consistent with these studies that point to the importance
of presynaptic TrkB in BDNF-mediated synaptic plasticity.
Estradiol may cause the increase in axonal pTrkB by several different
mechanisms.  As described in Chapter 4, estradiol increases BDNF
expression, which could increase TrkB activation in proportion to BDNF
availability.  Estradiol also increases BDNF release in the CA3 of the rat
hippocampus, which could increase presynaptic TrkB activation (Sato et al.,
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2007). In addition, estradiol enhances retrograde transport of BDNF in the
rat basal forebrain (Jezierski and Sohrabji, 2003).  If this occurs in the mouse
hippocampus, increased pTrkB transport from axon terminals could directly
increase pTrkB-ir in axons.   Finally, estradiol may affect TrkB signaling
indirectly by augmenting calcium influx (Wu et al., 2005; Zhao et al., 2005).
Such increases in neuronal activity rapidly enhance TrkB insertion into the
membrane, kinase activity, and pTrkB endocytosis (Du et al., 2000; Du et
al., 2003), events which may be involved in the “tagging” of active synapses
(Nagappan and Lu, 2005).  Without knowledge of the relative role of each of
these mechanisms, the results of the current study suggest that the
coordinated increase in neuronal activity and BDNF availability during
proestrus specifically increase presynaptic TrkB activation in the CA1
stratum radiatum and CA3 stratum lucidum.  The downstream effects of this
increased presynaptic pTrkB could include enhanced synaptic plasticity
through more efficient synaptic “tagging,” and the creation of new
presynaptic sites.
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Sex differences in the distribution of pTrkB may reflect the influence of
estradiol
The distribution of pTrkB-ir in male mice resembled that of low-
estradiol (estrus or diestrus) females.  Specifically, males had less pTrkB-ir
in axons in the CA1 stratum radiatum and CA3 stratum lucidum than
proestrus females, and more pTrkB-ir in axon terminals in the stratum
lucidum than proestrus or estrus females.  This similarity between males and
low-estradiol females means that estradiol likely mediates any sex
differences in BDNF/TrkB signaling.  Indeed, the behavioral effects of
BDNF reduction in mice differ significantly in males and females, and some
of these differences may be explained by the presence or absence of
estradiol (Monteggia et al., 2006; Ren-Patterson et al., 2006). In females, the
ability of estradiol to increase presynaptic TrkB activation may protect
females against some of the effects of BDNF reduction.
Summary
This ultrastructural localization of pTrkB in the mouse hippocampal
formation shows pTrkB well positioned to carry out local effects of BDNF
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in synapses and neurites, and more sustained effects via retrograde transport
and activation of gene transcription.  It provides evidence that presynaptic
TrkB is important for the maintenance of hippocampal function, as the
majority of pTrkB-ir was found in axons and terminals.  Furthermore, this
axonal pTrkB-ir increased during the high-estradiol stage of the estrous
cycle, proestrus.  This is strong evidence for the importance of presynaptic




BDNF variant Val66Met modifies the estrous cycling
of hippocampal function
The molecular endpoints studied in this thesis were chosen because of
their importance to hippocampal synaptic function, and therefore their
possible relevance to estradiol effects on hippocampal-dependent learning
and memory.  For this reason, it is important to relate these molecular effects
of estradiol to behavior.  To do this, I studied estrous cycle fluctuation of
behavior in wild-type mice, and mice with a specific disruption in BDNF
signaling.
The BDNF variant Val66Met is a single nucleotide polymorphism in
the pro region of the BDNF gene, found commonly in certain human ethnic
groups; it is carried by 20-30% of Caucasians (Shimizu et al., 2004).
Neurons expressing the Met variant show impaired trafficking of pro-BDNF
and approximately 30% less activity-dependent BDNF secretion (Egan et al.,
2003; Chen et al., 2004; Chen et al., 2006).  The study of estradiol effects in
these mice will therefore provide information about the importance of
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activity-dependent BDNF secretion in these effects.  Furthermore, because
of the high prevalence of this BDNF variant in certain human populations,
the findings are potentially clinically relevant.
For these studies, I collaborated with Dr. Francis Lee in his laboratory
at Weill Cornell Medical College to conduct experiments on transgenic mice
expressing the BDNF Val66Met variant. Behavioral experiments were
conducted using wild type (Val/Val) and homozygous variant (Met/Met)
female mice, which were then sacrificed in proestrus and diestrus.
This was the first thorough investigation of behavior in female
Val66Met mice.  Because of this, the first set of studies sought to identify
overall genotype differences in non-mnemonic and mnemonic behaviors.
To study fluctuation of hippocampal function across the estrous cycle,
spatial memory was tested in several difference phases of the estrous cycle.
Estrous cycles were carefully monitored and followed up with molecular
studies to discover any major genotype effects on reproductive function that
could confound study results.  To relate the behavioral and molecular
findings, immunocytochemistry and in situ hybridization assays were
conducted for the following endpoints in sections through the dorsal
hippocampal formation: BDNF mRNA, TrkB mRNA, pTrkB-ir, pAkt-ir,
and PSD-95-ir.
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Met/Met mice are reproductively normal
The hormonal control of reproduction is centered on the
hypothalamic-pituitary-gonadal (HPG) axis, which regulates circulating
hormone levels through complex positive and negative feedback loops.  The
resulting fluctuations in ovarian steroids across the estrous cycle induce
measurable changes in reproductive behavior, vaginal cytology, and
hypothalamic gene expression.
Met/Met females had regular estrous cycles, with characteristic length
and vaginal cytology, which were indistinguishable from Val/Val cycles.
These mice reproduce normally, with no obvious differences in reproductive
or maternal behavior. This suggests no significant changes in HPG axis
function in Val/Val and Met/Met mice.  To substantiate these qualitative
assessments with a quantitative measure, progesterone receptor (PR)
expression was examined in the medial preoptic nucleus (MPO) of the
hypothalamus, where neurons release gonadotropin-releasing hormone in
response to hormonal stimuli.  Estradiol induces PR expression in this
region, most likely via nuclear ERs (Kudwa et al., 2004).  Proestrus mice
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should therefore show increased PR expression in the MPO relative to
diestrus mice.
In sections through the MPO labeled with anti-PR antibody, cells
expressing PR were counted in a fixed polygon of area 6556.91 µm2 in the
MPO from each hemisphere (Figure 61).
Figure 6.1 PR expression increases during proestrus in BDNF Val66Met
mice.  PR-positive cells were counted from a fixed area in the medial
preoptic area of the hypothalamus.  PR mRNA was significantly higher in
proestrus than diestrus in both Val/Val and Met/Met mice. R.O.D., relative
optical density. *, p<0.05. PR, progesterone receptor; MPO, medial preoptic
area.  N = 6 for Val/Val proestrus, 4 for Val/Val diestrus, 5 for Met/Met
proestrus, and 4 for Met/Met diestrus.
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The number of PR-labeled cells in this area was higher in proestrus than
diestrus in both Val/Val and Met/Met genotypes (Figure 6.1).  Two-way
ANOVA with genotype and cycle phase as the independent factors showed a
significant overall effect of genotype (F(1, 16) = 32.42, p < 0.0001).  Post-
hoc tests revealed that for both genotypes, the density of PR-labeled cells
increased significantly during proestrus (p<0.05 for both).
In sum, BDNF Met/Met mice are reproductively normal, with no
differences in vaginal cytology, reproductive behavior, or cyclic PR
expression in the MPO.  These findings suggest no differences in circulating
ovarian steroid levels or nuclear ER activity between Val/Val and Met/Met
mice.
Met/Met mice show differences in non-mnemonic behaviors
To test the effects of the BDNF variant Val66Met on behavior in
females, female Met/Met and wild-type Val/Val littermates in mixed estrous
cycle phases were tested on two tests of short-term memory, novel object
placement recognition (OP) and novel object recognition (OR).  Both tests
consisted of a sample trial and a recognition trial separated by an intertrial
delay.  The OP test uses two familiar, identical objects to assess recognition
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of a new object location relative to external cues. The OR test uses novel
objects to assess recognition of a new object identity.  Both tests are often
used to assess hippocampal function in rodents, though other brain regions
play a major role in OR performance (Luine, 2006; Good et al., 2007).  In
addition to object and place recognition, two non-mnemonic behaviors were
recorded during the sample trials: the amount of time spent in the center of
the open field, and total object exploration.  The center time is a commonly
used measure of anxiety behavior in rodents, where less time signifies
increased anxiety-type behavior.
Met/Met females spent significantly less time in the center of the open
field during the sample trial of both OP (p = 0.0437) and OR (p = 0.0240)
tests (Figure 6.2A and B).  There was no difference between genotypes in
time spent exploring the two identical, familiar objects in the OP sample trial
(Figure 6.2C).  In contrast, Met/Met females spent significantly less time
exploring the two identical, novel objects in the OR sample trial (6.2A and
D; p = 0.0222).  In sum, Met females exhibit increased anxiety behavior and








Figure 6.2 BDNF Val66Met affects non-mnemonic behaviors in female 
mice.  Anxiety and exploratory behavior were examined from the sample 
trials of the OP and OR test in BDNF Val66Met mice. (A) Diagram of the 
exact path of one representative mouse of each genotype during a sample 
trial of the object recognition test as recorded by the Noldus software. White 
circles represent objects, and white squares represent the center of the open 
field used for quantification. (B) Anxiety-related behavior was measured as 
the amount of time spent in the center of the open field, where less time in 
the center is interpreted as higher anxiety-related behavior.  Met/Met 
females spent significantly less time in the center than Val/Val females 
during the sample trials of both OP and OR tasks. (C) Exploratory behavior 
was measured as the amount of time spent exploring both objects.  Met/Met 
females spent significantly less time exploring the objects during the sample 



















Met/Met mice exhibit memory impairment
The OR and OP tests rely on a mouse’s tendency to explore a novel
object (or object location) more than a familiar one, thereby testing
recognition of the familiar object or object placement.  Object recognition
relies on the hippocampal formation, parahippocampal cortices, and other
brain regions in rodents, while object placement recognition is particularly
dependent on hippocampal function (Dere et al., 2007; Squire et al., 2007).
In order to successfully utilize these tasks to compare memory and
hippocampal function in BDNF Val66Met mice, it was necessary to confirm
that Met/Met females retain their preference for novelty when presented
with one familiar and one novel object. This is especially important
considering that Met/Met mice explored novel objects less than Val/Val
females in the OR sample trial (Figure 6.2).
To determine novelty preference in both genotypes, mice were tested
on the OR task using an easily differentiated pair of objects (chosen based
on experience).  The amount of time spent exploring the novel object during
the recognition trial was expressed as a fraction of the time spent with both
objects, termed “novel object fraction.”  If the mouse spent the same amount
of time with both objects, a result consistent with no object preference, the
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novel object fraction would be 0.5.  Therefore, “chance” performance was
defined as a fraction of 0.5, and “recognition” was defined as a fraction
significantly greater than 0.5 (using a one-sample t-test).
Val/Val and Met/Met females both recognized the novel object
(Figure 6.3A; p < 0.0001 for Val/Val and p = 0.0103 for Met/Met).  This
suggests that the Met/Met mice do indeed prefer novel objects, and therefore
the OP and OR tasks are appropriate tests of memory.
To explore possible genotype differences in object recognition, mice
were tested again on the OR task using a new, less easily differentiated,
object pair (Figure 6.3B).  This time, Val/Val mice recognized the novel
object (p = 0.0090), while Met/Met mice did not.  Mice were also tested on
the OP task (Figure 6.3C).  Again, Val/Vals recognized the novel object
placement (p = 0.0181), while Met/Mets did not.  Thus compared to wild












Figure 6.3 BDNF Val66Met impairs memory OP and OR performance 
was measured using the novel object fraction, where 0.5 (dotted line) 
represents chance performance.  (A) Val/Val and Met/Met females 
recognized the novel object in an OR test using easily distinguishable 
objects, indicating that both genotypes show preference for novel objects. 
(B) Val/Val but not Met/Met females recognized the novel object in an OR 
test using less easily distinguishable objects. (C) Val/Val but not Met/Met 
females recognized the novel object placement.  *, p<0.05 relative to chance.  
























Estrous cycle affects the Val66Met cognitive phenotype
When mice are tested on the OP task repeatedly on different days, no
overall change in performance is seen, suggesting no effect of practice on
OP performance (personal experience and (Luine et al., 2003)).  Val/Val and
Met/Met mice were therefore tested repeatedly in each of four estrous cycle
phases: proestrus, estrus, diestrus 1, and diestrus 2, to assess the effect of
estrous cycle phase on spatial memory.  Since all Val/Val females
recognized the new object placement on their first OP test (Figure 6.3C),
with a 5 minute intertrial delay, the task was made more difficult by
increasing the intertrial delay to 30 minutes, to increase the likelihood of
detecting differences in performance across the cycle.
OP performance fluctuated across the estrous cycle for both Val/Val
and Met/Met females (Figure 6.4).  The new object fraction was
significantly greater than chance in diestrus for Val/Vals (p = 0.0038), and
proestrus for Met/Mets (p = 0.0318).  Spatial memory was therefore best
during diestrus in Val/Val mice, and proestrus in Met/Met mice.
Performance was also analyzed using two-way repeated measures ANOVA,
with cycle phase and genotype as the independent variables.  There was a
significant interaction between genotype and cycle phase on object
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placement test performance (F(3, 36) = 2.962, p = 0.0450), indicating that
the effect of the Met variant on OP performance depended on estrous cycle
phase.  There were no differences in non-mnemonic behaviors between
genotypes or across the cycle, including mobility and exploratory behavior.
Thus, independent of non-mnemonic factors that could enhance
performance, spatial memory peaks during different estrous cycle stages in
wild type Val/Val and BDNF variant Met/met mice.
Figure 6.4 Estrous cycle and BDNF genotype interact to control OP
performance.  Val/Val and Met/Met mice were tested on the OP task in late
morning of four different estrous cycle stages. Only Val/Val females in
diestrus and Met/Met females in proestrus recognized the novel object
placement, and two-way ANOVA showed a significant interaction between
genotype and estrous cycle stage (p<0.05).  *, p<0.05 relative to chance.  N
= 8.
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Met/Met hippocampi show increased BDNF and TrkB expression
Expression of BDNF and TrkB in the Val/Val and Met/Met mice was
assayed using in situ hybridization in sections through the dorsal
hippocampal formation (Figure 6.5). BDNF mRNA was measured in the
CA3 pyramidal cell layer, where expression fluctuates across the estrous
cycle in female rats (Scharfman et al., 2003).  Similar to rats, BDNF mRNA
was increased in proestrus compared to diestrus (Figure 6.5A).  This was
true for both Val/Val and Met/Met mice; one-way ANOVA showed a
significant overall effect of cycle phase (F(1, 15) = 7.994, p = 0.0127).
Furthermore, compared to the wild type Val/Vals, Met/Met mice had
increased BDNF mRNA; one-way ANOVA showed a significant overall
effect of genotype (F(1, 15) = 10.17, p = 0.0061).
TrkB mRNA was measured in the CA1 pyramidal cell layer, as in
Chapter 4 (Figure 6.5B).  Consistent with the results in Chapter 4, there was
no significant fluctuation of TrkB mRNA across the estrous cycle.  As with
BDNF, TrkB mRNA was increased in Met/Mets compared to Val/Vals; one-
way ANOVA showed a significant overall effect of genotype (F(1, 13) =











Figure 6.5 BDNF Val66Met mice have increased hippocampal BDNF 
and TrkB expression (A) Optical density of BDNF mRNA from in situ 
hybridization films was measured in the CA3 pyramidal cell layer of the 
hippocampus and normalized to background density.  BDNF mRNA was 
significantly increased during proestrus relative to diestrus in the combined 
sample.  In addition, Met/Met females had significantly more BDNF than 
Val/Val females.  (B) Optical density of TrkB mRNA from in situ 
hybridization films was measured in the CA1 pyramidal cell and normalized 
to background density.  Met/Met females had significantly more TrkB 
mRNA than Val/Val females. R.O.D., relative optical density. * p<0.05. N = 
6 for Val/Val proestrus, 4 for Val/Val diestrus, 5 for Met/Met proestrus, and 















In sum, BDNF mRNA but not TrkB mRNA increased significantly
during proestrus compared to diestrus.  BDNF and TrkB mRNA were
significantly increased in BDNF variant Met/Met compared to wild type
Val/Val females.
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Val66Met alters estrous cycle fluctuation of pAkt and PSD-95
The proestrus increase in BDNF mRNA in both Val/Val and Met/Met
females suggests that estradiol increases hippocampal BDNF expression in
both genotypes.  However, since spatial memory peaks during different
estrous cycle phases in Val/Val and Met/Met mice, there must be some
difference in how estradiol affects hippocampal function in these genotypes.
To address this, immunocytochemistry for pTrkB, PSD95, and pAkt was
performed in tissue sections through the dorsal hippocampal formation.
Based on previous chapters in this thesis, I expected that all of these
endpoints would increase during proestrus in the wild type (Val/Val)
females.  To compare proestrus changes between genotypes, proestrus
values for each endpoint were expressed as % change from diestrus, and
these changes were directly compared between genotypes.  Raw data
(optical density normalized to background for each endpoint) was also
compared between genotypes and cycle phases using two-way ANOVA.
Based on the proestrus increase in BDNF, it was not surprising that
pTrkB-ir increased during proestrus in both Val/Val and Met/Met mice, with
no difference between genotypes (Figure 6.6).  Two-way ANOVA
confirmed an overall effect of estrous cycle phase on pTrkB-ir in CA1
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stratum radiatum (F (1,15) = 5.467, p = 0.0336) and dentate hilus (F (1, 15)
= 8.502, p = 0.012).
Figure 6.6 Normal estrous cycle fluctuation of pTrkB-ir in BDNF
Val66Met mice. Proestrus changes in pTrkB-ir were expressed as a percent
increase over diestrus pTrkB-ir in several hippocampal subregions.  pTrkB-
ir increased during proestrus in both Val/Val and Met/Met females.  There
was no significant difference in proestrus changes between the two
genotypes. SR, stratum radiatum; SL, stratum lucidum; DG HIL, hilus of the
dentate gyrus. N = 6 for Val/Val proestrus, 4 for Val/Val diestrus, 5 for
Met/Met proestrus, and 4 for Met/Met diestrus.
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As expected based on the estrous cycle fluctuation of, pAkt-ir in wild-
type mice (Chapter 3), pAkt-ir increased during proestrus in Val/Val females
(Figure 6.7A).  However, pAkt-ir actually decreased during proestrus in
Met/Met females.  The proestrus changes in pAkt-ir differed significantly
between Val/Val and Met/Met genotypes in all hippocampal subregions
(CA1 stratum radiatum, p = 0.0026; CA3 stratum radiatum, p = 0.0176;
dentate hilus, p = 0.0029).  Two-way ANOVA confirmed that estradiol
affected pAkt differently in Val/Val and Met/Met females, showing a
significant interaction between cycle phase and genotype in CA1 stratum
radiatum and dentate hilus, and a strong trend in the CA3 stratum radiatum
(CA1 stratum radiatum, F(1, 15) = 8.615, p = 0.0102); CA3 stratum










Figure 6.7 Abnormal estrous cycle fluctuation of pAkt-ir and PSD-95-ir 
in BDNF Val66Met mice.  (A and B) Proestrus changes in pAkt-ir and 
PSD-95-ir were expressed as a percent increase over diestrus levels in 
several hippocampal subregions.  pAkt-ir and PSD-95-ir increased markedly 
during proestrus in Val/Val mice, and decreased slightly during proestrus in 
Met/Met mice.  Proestrus changes differed significantly between genotypes 
for both pAkt-ir and PSD-95-ir, in all hippocampal subregions. SR, stratum 
radiatum; SL, stratum lucidum; DG HIL, hilus of the dentate gyrus. *, 
p<0.05.  N = 6 for Val/Val proestrus, 4 for Val/Val diestrus, 5 for Met/Met 
























PSD-95-ir also increased during proestrus in Val/Val females (Figure
6.7B). Similar to pAkt-ir, PSD-95-ir did not increase during proestrus in
Met/Met females, and even decreased slightly.  The proestrus changes in
PSD-95-ir differed significantly between Val/Val and Met/Met genotypes in
all hippocampal subregions measured (CA1 stratum radiatum, p = 0.0117;
CA3 stratum radiatum, p = 0.007; dentate hilus, p = 0.0127).  Two-way
ANOVA confirmed that estradiol affected PSD-95 differently in Val/Val
and Met/Met females, with a significant interaction between cycle phase and
genotype in all hippocampal subregions (CA1 stratum radiatum, F(1, 15 =
9.088, p = 0.0087); CA3 stratum radiatum, F(1, 15) = 6.457, p = 0.0226;
dentate hilus, F (1, 15) = 7.161, p = 0.0173).
In sum, compared to wild type Val/Val females, Met/Met females
show similar estrous cycle fluctuation of TrkB activation, but opposite
fluctuation of Akt activation and PSD-95 expression.  These opposite effects
on Akt and PSD-95 correlate with the opposite estrous cycle fluctuation of
spatial memory in Val/Val and Met/Met females.
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Discussion
This study of hippocampal function across the estrous cycle in BDNF
variant Val66Met mice provides a wealth of new information about estradiol
effects in the hippocampus.  The findings pertain to ovarian steroid effects in
wild-type mice, the role of activity-dependent BDNF secretion in these
effects, and possible interactions between ovarian steroids and human gene
variants in the control of behavior.
Behavioral and molecular effects of BDNF variant Val66met
Many studies have investigated the effects of BDNF Val66Met on
behavior and neuropsychiatric disorders in humans.  The behavioral
characterization of the BDNF Val66Met mouse is just beginning, with the
hope that it will be a useful model for the study of how this gene variant
affects behavior.  The current study revealed important behavioral
phenotypes in anxiety, exploratory, and memory behaviors in female
Val66Met mice.
Met/Met females had increased anxiety-type behavior compared to
Val/Vals.  A similar effect of the Met allele was found in male mice (Chen
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et al., 2006).  Human studies have shown variable effects of the Val66Met
variant on anxiety, but several reports suggest that the Met allele predisposes
to anxiety traits and disorders (Jiang et al., 2005; Gatt et al., 2009).
Met/Met females explored novel objects less than Val/Val mice,
though they retained their preference for a novel object when that object was
paired with a familiar one.  This finding may reflect complex effects of the
Met allele on motivational or novelty-seeking behavior that deserve further
scrutiny.  Human Met carriers have decreased susceptibility to substance
abuse that could, with further study, be related to reduced novelty-seeking
behavior in Met/Met mice (Gratacos et al., 2007).
Finally, Met/Met mice had impaired memory, measured as OP and
OR performance, compared to Val/Vals.  Consistent with these findings,
human Met carriers have slightly lower IQ and poorer episodic memory
(Egan et al., 2003; Hariri et al., 2003; Tsai et al., 2004).  Overall, the
behavioral phenotype of the female BDNF Met/Met mice in this study was
generally consistent with the effects of the Met allele on human behavior,
validating the utility of this mouse model for studying the behavioral effects
of this polymorphism.    
In situ hybridization studies showed increased BDNF and TrkB
expression in the Met/Met female hippocampus.  This suggests that in
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Met/Met mice, hippocampal cells may attempt to compensate for the
deficiency in activity-dependent BDNF release by an upregulation of BDNF
and its receptor, thereby increasing the BDNF release pool and the
sensitivity to secreted neurotrophin.  This idea remains to be tested, but it is
consistent with the finding of elevated BDNF serum concentrations in
human Met carriers (Lang et al., 2009).  A similar hypothesis was proposed
to explain the upregulation of TrkB expression after stress, when BDNF
levels are reduced (Nibuya et al., 1999).  In the current study, there was no
overall difference in hippocampal TrkB activation, measured as pTrkB-ir,
between genotypes.  This suggests that the increased BDNF and TrkB
expression in Met/Met females at least partially compensate for the BDNF
deficiency.  But this apparent compensation did not prevent the Met
behavioral phenotype.
Estradiol effects in wild type (Val/Val) mice
  The current study confirmed the findings from Chapters 3 and 4 that
TrkB and Akt activation increase during proestrus throughout the
hippocampal formation, while TrkB expression remains unchanged.  BDNF
mRNA also increased during proestrus, consistent with a previous report in
126
rats (Scharfman et al., 2003).  Combined with the estradiol induction of
BDNF described in Chapter 4, this indicates that both endogenous and
exogenous increases in circulating estradiol increase BDNF expression in
the mouse hippocampus.  This increased BDNF expression likely mediates
the associated increase in TrkB activation.  Finally, PSD-95 expression also
increased during proestrus throughout the hippocampal formation.  Although
this finding is consistent with the effects of estradiol treatment in mice
(Chapter 3 and (Li et al., 2004)) this is the first demonstration that natural
fluctuations in ovarian steroids affect synaptic protein expression.
Hippocampal function across the estrous cycle was assessed in the
mice using the object placement test of spatial memory.  The wild type mice
performed best during diestrus, when estradiol levels are low and
progesterone levels high.  This was surprising given that in female rats,
several studies have shown an enhancement of spatial memory, including
OP performance, during proestrus (Frye et al., 2007).  In addition, the
parameters that increased during proestrus in the mouse hippocampus,
including BDNF activity, Akt activation, and PSD-95 expression, all
function in excitatory synapse development, synaptic plasticity, and/or
spatial memory (see Chapter 1).  It was therefore expected that these
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parameters would correlate positively with spatial memory across the estrous
cycle.
There are several possible explanations for this finding.  First, the OP
task may depend on other brain regions besides the hippocampal formation.
The hippocampus is crucial for spatial recognition memory in rats (Good et
al., 2007), but its role in this behavior, and the relative role of the
parahippocampal cortex and other brain regions, has not been investigated in
mice.  The balanced contribution of different brain regions to a behavior is
important for the potential effects of estradiol on that behavior (Korol,
2004).  Previous work has indeed demonstrated that mice and rats use
different strategies to solve similar tasks of spatial navigation (Frick et al.,
2000).  Because of this, direct comparison of behavioral studies between
mice and rats is not always appropriate.
A second possibility is that spatial memory is not enhanced during
proestrus in the mouse.  The OP testing took place in the late morning of
proestrus, at the same time that the effects of circulating estradiol on Akt,
PSD-95, and BDNF in the hippocampus were observed.  These widespread
molecular events could obscure the specific synaptic events required to form
a short-term memory during the sample trial.  For example, in rat
hippocampal neurons, overexpression of PSD-95 dramatically increases
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excitatory postsynaptic potentials, occluding the synaptic potentiation seen
in control neurons (Stein et al., 2003).  If this phenomenon is applicable to
the proestrus mouse hippocampus, more long-term estradiol treatment or
estradiol administration after the sample trial might still be expected to
enhance memory formation or consolidation.  Indeed, mice show enhanced
spatial memory after six days of estradiol treatment, or post-training
estradiol injections (Li et al., 2004; Gresack and Frick, 2006).
As indicated in the Introduction (Chapter 1), this is not the first study
to find improved hippocampal-dependent memory when circulating estradiol
is low.  Previous studies showed varied estrous cycle fluctuation of different
memory tasks in female rats, including water maze navigation and novel
object recognition (Frick, 2009).  The best conclusion based on all available
data is that memory and hippocampal function do fluctuate across the
estrous cycle, but the consequences of this fluctuation for behavior are
complex and particularly task-dependent.  With all this in mind, the current
study demonstrates that natural fluctuations in ovarian steroids affect spatial
memory in female mice.  Object placement recognition increases during
diestrus, and correlates inversely with hippocampal BDNF expression, TrkB
activation, Akt activation, and PSD-95 expression.
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Estradiol effects in BDNF variant Val66Met mice
The BDNF Val66Met mouse is an ideal model to assess the role of
BDNF in estradiol effects because of the specific deficiency in activity-
dependent BDNF secretion. Activity-dependent, or regulated, BDNF
secretion occurs in response to neuronal activity through a specific neuronal
secretory pathway (Lessmann et al., 2003).  This regulation of secretion is at
the heart of BDNF’s role in activity-dependent synaptic modifications
(Boulanger and Poo, 1999; Lim et al., 2003), and therefore may be pertinent
to estradiol effects on synaptic plasticity.  Because the Val66Met variant
leaves the constitutive pathway of neurotrophin secretion intact, it is in some
ways less dramatic than a BDNF knockout.  At the same time, it allows for
the specific assessment of the role of activity-dependent BDNF secretion in
estradiol effects.
Using female mice homozygous for wild type BDNF or the Val66Met
variant, the current study demonstrated that this variant does not eliminate
the fluctuation of spatial memory across the estrous cycle, but alters it
dramatically. OP performance peaked during the low-estradiol stage of
diestrus in Val/Val mice, and during the high-estradiol stage of proestrus in
Met/Met mice. In concert with their different estrous cycling of OP
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performance, Val/Val and Met/Met females also showed a different
fluctuation of Akt activation and PSD-95 expression across the cycle.  Akt
activation and PSD-95 expression in the hippocampal formation increased
during proestrus as expected in Val/Val females, but decreased during
proestrus in Met/Met females.  Thus compared to Val/Vals, female
Met/Mets exhibited a coordinated change in the estrous cycle fluctuation of
spatial memory, Akt activation, and PSD-95 expression.
The effect of the BDNF variant Val66Met on estrous cycling of Akt
and PSD-95 suggests that activity-dependent BDNF secretion plays a critical
role in the widespread increase in hippocampal Akt activation and PSD-95
expression during proestrus. Since estradiol acts rapidly on Akt and PSD-95,
(Chapter 3), this implicates activity-dependent BDNF secretion in rapid,
membrane-initiated estradiol signaling. Furthermore, the correlation among
spatial memory, Akt activation and PSD-95 expression in this study suggests
that these specific rapid signaling events may be especially important for
estradiol effects on hippocampal-dependent behavior. The BDNF variant
Val66Met did not alter the more delayed effects of estradiol on PR and
BDNF expression.
Surprisingly, Met/Met mice actually performed better than Val/Vals
on the 30-minute OP test during proestrus.  This was unexpected in light of
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their overall impairment on the 5-minute OP task when tested in mixed
estrous cycle stages.  This suggests that in some cases, the effects of
circulating ovarian steroids are robust enough to overcome the global
behavioral phenotype of this BDNF variant.  Alternatively, the 5- and 30-
minute OP tasks may test different aspects of brain function. In rats, the role
of the hippocampal formation in recognition memory depends on the
intertrial delay (Hammond et al., 2004).  If this holds true in mice, it would
suggest that the memory impairment in Met/Met females depends on the
specific memory task and its dependent brain regions.
In sum, the BDNF variant Val66Met leads to opposite effects of
increased circulating estradiol on hippocampal function measured by Akt
activation, PSD-95 expression, and OP performance in female mice. These
different effects of circulating ovarian steroids in Val and Met genotypes
may stem from developmental or adult differences in BDNF biology.
Though the actual mechanism is unclear, activity-dependent BDNF secretion
appears to play a critical role in how estradiol effects on hippocampal
function.
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Implications for human behavior
The BDNF variant Val66Met fascinates researchers because of its
association with variations in human behavior, including susceptibility to
several neuropsychiatric disorders and the course of these diseases.  These
effects clearly underscore the importance of BDNF in nervous system
development and adult brain function.  Studying this polymorphism will
provide more information not only about basic BDNF biology, but also
about genetic variation in human behavior.
Most women report mood and cognitive changes associated with the
menstrual cycle, and 5-10% meet strict diagnostic criteria for premenstrual
dysphoric disorder (PMDD) (Yonkers et al., 2008).  Affective behavior,
including mood, in humans depends on the cooperation of multiple brain
areas including the hippocampal formation.  Common genetic variation in
some of the molecular mediators of estradiol effects on these brain regions
could explain why some women develop severe behavioral symptoms
associated with the menstrual cycle, while others experience little change in
mood or cognitive function.  Based on the current findings, the BDNF
variant Val66Met is a strong candidate for one such genetic factor.  Val/Val
and Met/Met female mice showed different estrous cycle fluctuation of
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behavior and several molecular endpoints in the hippocampal formation.
This BDNF variant may therefore play a role in determining how the female
brain responds to ovarian steroids, and may influence susceptibility to
PMDD and other disorders associated with changes in circulating ovarian
steroids.
The striking interaction between BDNF genotype and circulating
ovarian steroids suggests that an interaction between the Met allele and
estradiol may also contribute to gender differences in the effects of the Met
allele on human behavior.  A recent meta-analysis showed that female sex
may protect Met carriers against an increased risk for major depressive
disorder (Verhagen et al., 2008).  In one study, the Met allele had opposing
effects on the course of obsessive-compulsive disorder: it was associated
with earlier onset in males but decreased severity in females (Hemmings et
al., 2008).  Future lab and clinical studies should be designed to specifically
assess gender differences in the effects of the Met allele, and the
contribution of sex hormones to these differences.  This information will be
critical to the successful application of clinical data to genetic risk




The goal of this thesis was to make progress toward understanding
how estradiol affects hippocampal function in female mice.  Two candidate
molecular mediators of estradiol effects were investigated based on their
relevance to synaptic plasticity and hippocampal function: the
serine/threonine kinase Akt, and the neurotrophin BDNF.  The effect of
estradiol on these molecules was determined using intact cycling mice and
estradiol replacement in ovariectomized mice.  The studies also took
advantage of several existing lines of transgenic mice to determine the role
of estrogen receptors and BDNF in estradiol actions.
The results of these studies shed light on several key aspects of how
estradiol affects hippocampal function: the upstream signaling pathways and
target genes on which estradiol acts, which estrogen receptors mediate these
effects, and the importance of these pathways in the downstream increase in
synaptic protein expression. In addition to these important mechanistic
points, these studies also demonstrate potentially important differences
between the effects of physiologic and pharmacologic increases in
circulating estradiol.
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Mechanism of estradiol effects on hippocampal function
These studies clearly demonstrate that estradiol increases Akt and
BDNF signaling in the mouse hippocampal formation.  Estradiol activates
Akt on a fairly rapid time course consistent with a membrane-initiated event.
In contrast, estradiol increases BDNF expression on a more delayed time
course consistent with a requirement for new gene transcription.  Estradiol
also increases TrkB activation, which occurs without any change in TrkB
expression and is therefore likely mediated by estradiol effects on BDNF
expression.
In these studies, estrogen receptors alpha and beta were both essential
for estradiol effects in the mouse hippocampal formation.  ER alpha was
required for estradiol activation of Akt, while ER beta was required for both
estradiol activation of Akt and induction of BDNF.  The unique roles of
these receptors will be important in the consideration of the effects of
different estrogenic compounds, with distinct affinities for the two ERs, on
brain function.  Additionally, once the role of each receptor is clear, we may
more clearly understand how changes in estrogen receptor expression across
the lifespan influence estradiol sensitivity.  For example, aging is associated
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with decreased synaptic localization of ER alpha in the CA1 stratum
radiatum of the hippocampus of female rats (Adams et al., 2002).  Decreased
synaptic ER alpha would impair the ability of estradiol to activate Akt in
synapses, where Akt is linked to actin-remodeling pathways required for
dendritic spine remodeling.  This could explain the impaired estradiol
regulation of spine morphology and density in the aging brain (Adams et al.,
2001; Yildirim et al., 2008).
The choice to examine PSD-95 expression as a marker of downstream
modulation of synaptic plasticity in this study was based primarily on two in
vitro studies suggesting that Akt and BDNF are important for estradiol to
increase PSD-95 expression.  In the study supporting a role for BDNF,
estradiol increased PSD-95 expression in rat hippocampal slices through a
Trk receptor-dependent mechanism (Sato et al., 2007).  In the study
supporting a role for Akt, estradiol rapidly increased PSD-95 protein
translation in the NG108-15 neuroblastoma cell line through a PI3K-
dependent mechanism (Akama and McEwen, 2003).  In the current study,
there was a close relationship between the rapid effect of estradiol on Akt
and PSD-95, in the CA1 stratum radiatum, and the more prolonged effect of
estradiol on BDNF and PSD-95, in the CA3 stratum radiatum.  Although
these data are purely correlative, they support the findings of both in vitro
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studies, suggesting that when circulating estradiol increases, both Akt and
BDNF are involved in increasing PSD-95 expression in the mouse
hippocampus.
Physiology vs. Pharmacology
In this thesis, consistent use of the same molecular assays allowed
side-by-side comparison of the effects of physiologic increases in circulating
estradiol during proestrus, and pharmacologic increases following estradiol
injection.  In general, these studies led to similar conclusions: estradiol
increases Akt and BDNF signaling, and PSD-95 expression, in the mouse
hippocampal formation.  But there were some important differences, as
physiologic and pharmacologic increases in circulating estradiol had
anatomically and temporally distinct effects on Akt and BDNF signaling.
While the proestrus increase in Akt activation occurred throughout the
dorsal hippocampal formation, it occurred only in the CA1 6 hours after a
single estradiol injection.  This suggests that rapid estradiol signaling is most
robust in the CA1. The original description of estradiol effects on dendritic
spine density in the rat hippocampus focused on this subregion, where the
most robust changes occured (Woolley et al., 1990).  Since then
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investigators have acknowledged that estradiol does affect other
hippocampal subregions (Rudick and Woolley, 2000; Scharfman et al.,
2007).  In particular, estradiol effects in the CA3 and dentate gyrus can be
seen after a more prolonged estradiol exposure, as chronic estradiol
increases PSD-95 expression throughout the hippocampal formation (Li et
al., 2004).  Indeed, in the current study a more prolonged 48 hour estradiol
treatment increased BDNF expression, TrkB activation, and PSD-95
expression in the CA3 region.  As with Akt, these effects occurred
throughout the hippocampal formation during proestrus.
What all this suggests an anatomical and temporal separation of Akt
and BDNF activity after estradiol treatment, but a convergence of these
effects during proestrus.  The rise and fall of circulating estradiol across the
estrous cycle, is therefore uniquely timed for a convergence of rapid and
delayed estradiol effects on the late morning of proestrus.  This elegant
orchestration may optimize cooperation between these two types of estradiol
signaling (Hammes and Levin, 2007).  For example, in numerous cell types,
the rapid effects of estradiol lead to the phosphorylation of transcription
factors (including ERs themselves) and coactivators important for the
delayed effects on gene expression (Vasudevan et al., 2001; Levin, 2005).
Estradiol activation of Akt could in this way support increase TrkB
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activation in the CA1 during proestrus.  Conversely, the gradual increase in
circulating estradiol beginning in diestrus 2 may effect changes in gene
transcription that support the rapid effects of peak circulating estradiol on
proestrus morning (Scharfman et al., 2007). Estradiol induction of BDNF
and the resulting increase in TrkB activation could in this way support Akt
activation in the CA3 during proestrus.
In sum, the current study suggests that in mice, the precise timing of
increased circulating estradiol ensures activation of rapid and delayed targets
at the same time, in all hippocampal subregions. The convergence of these
signals during proestrus may have important consequences for hippocampal
function.  One recent paper provided evidence for this possibility in female
rats. Using a sequence of estradiol injections timed to mimic physiologic
fluctuations of estradiol, the authors showed that the precise timing of
increased circulating estradiol is important for the specific increase in
hippocampal cell excitability seen during proestrus (Scharfman et al., 2007).
In mice, such exaggerated changes during proestrus may not uniformly
enhance hippocampal-dependent memory.  In a test of object placement
recognition across the estrous cycle, mice performed best during diestrus,
indicating that the proestrus changes may actually impair spatial memory.
Based on the current studies it is impossible to know how 6 or 48 hours of
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estradiol treatment might differently impact performance on this test,
although in a previous study, six days of estradiol treatment enhanced
performance on the same test (Li et al., 2004).
Taking all this into account, it is clear that physiologic and
pharmacologic models are complementary approaches to the study of
estradiol effects in the brain, each reinforcing and informing the other. They
should be considered equally important, but not equivalent, models for the
study of basic ovarian steroid biology.
Working model
The new information acquired from this extensive body of work
permits me to propose a new working model of how estradiol affects
hippocampal function.
When circulating estradiol increases, the hormone acts rapidly on ERs
alpha and beta to activate Akt in the CA1 stratum radiatum.  This pAkt
activates actin-remodeling pathways that allow synaptic activity to be
translated into modifications of spine structure (Jaworski et al., 2005; Yuen,
2006), and increases PSD-95 protein translation.  The increased PSD-95
protein is targeted to dendritic spines, where its recruitment of AMPA
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receptors increases excitatory synaptic potentials, synergizing with the
effects of Akt to enable dendritic spine maturation (El-Husseini et al., 2000;
Beique et al., 2006).  Meanwhile, the increase in estradiol triggers a more
delayed increase in BDNF mRNA in CA3 pyramidal cells, via estrogen
receptor beta activation of CREB or direct nucleus-initiated signaling.  This
BDNF is soon secreted at active hippocampal synapses throughout the
hippocampal formation, where it activates TrkB, particularly in axon
terminals in CA3 stratum lucidum and CA1 stratum radiatum.  Some of this
pTrkB at axon terminals is transported down the axon to activate signaling
pathways in the cell body, leading to both local modifications at active
synapses and also widespread changes in gene expression, including an
increase in PSD-95.  The increase in TrkB activation serves to sustain and
amplify the rapid effects of estradiol on Akt, focusing them at active
synapses to better serve hippocampal synaptic plasticity.
The effects of estradiol on hippocampal-dependent behaviors depend
on the type of behavioral task, and the relationship of testing to circulating
ovarian steroids.  For example, mice show enhanced performance on an
object placement test of spatial memory during diestrus, when estradiol
levels are low.  The acute increase in Akt activation and PSD-95 expression
may be involved in this memory impairment during proestrus.
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In transgenic female mice, the BDNF Val66Met polymorphism
reverses the fluctuation of Akt activation, PSD-95 expression, and spatial
memory across the estrous cycle.  The mechanism for this reversal is
unclear, but it suggests that activity-dependent BDNF secretion is important
for estradiol activation of Akt.  In addition, it points to a possible interaction
between BDNF genotype and ovarian steroids in the control of human
behavior.
Relevance to human health
In women, shifts in circulating estradiol during puberty, across the
menstrual cycle, in pregnancy, and at the menopausal transition are all
associated with changes in mood and cognition (Aloysi et al., 2006).  The
role of estradiol in these changes has been difficult to determine, but several
human studies suggest a role for ovarian steroids in the cognitive impairment
following gonadal suppression, and the mood disturbances in premenstrual
dysphoric disorder (PMDD) (Sherwin and Tulandi, 1996; Schmidt et al.,
1998).  By exploring how estradiol regulates hippocampal function in
rodents, researchers hope to gain insights that will be applicable to ovarian
steroid effects on human behavior.  Some evidence suggests that translation
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of this work will be possible.  Several of the major effects of estradiol – on
spine density, synaptic protein expression, and cognition – are conserved
among mice, rats, and nonhuman primates (see Chapter 1).  The
conservation of these effects in several mammalian species suggests that
they serve an evolutionarily important role, and will probably be conserved
in humans.  One recent imaging study showed that gray matter volume in the
right anterior hippocampal formation fluctuates across the menstrual cycle in
women (Protopopescu et al., 2008).  A previous study showed that
postmenopausal women taking estrogen replacement therapy had increased
hippocampal volumes compared to women taking the ER partial agonist,
tamoxifen (Eberling et al., 2004).  This is direct evidence that estradiol
affects the hippocampus in women, fueling the hope that estradiol effects on
the mouse hippocampus may be directly applicable to women.
Contributions from animal studies
Despite the many animal studies that have begun to shed light on
estradiol effects in the mammalian brain, the translation of laboratory
knowledge into bedside practice has so far been inefficient.  This lack of
discussion between bench and clinical scientists is especially damaging in
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the realm of postmenopausal hormone replacement therapy.  In 2003, the
results from the large Women’s Health Initiative (WHI) study showed that
conjugated equine estrogens (CEE) with or without medroxyprogesterone
acetate (MPA) actually increased the risk of dementia and cognitive decline
in postmenopausal women (Rapp et al., 2003b; Shumaker et al., 2003; Craig
et al., 2005).  These findings were unexpected in light of the positive effects
of estrogen on many cognitive tests in animal studies and smaller
observational studies in humans.  Guided by comparisons between human
and animal studies, the research community has since come to a general
agreement over two major pitfalls of the study: first, the timing of hormone
replacement; and second, the type of hormone delivered (Sherwin, 2006;
Brann et al., 2007).
First, most of the women in the WHI study began hormone
replacement therapy more than ten years after the menopausal transition.
Investigators hypothesized that the brain loses its responsivity to estrogen
under a period of prolonged hypoestrogenicity, and that estrogen sensitivity
can be maintained through timely hormone replacement after the onset of
reproductive senescence. This idea, called the “healthy cell bias” or ‘critical
period” hypothesis, maintains that estrogen has positive effects on healthy
brain structures, but that once the structures are already damaged, estrogen’s
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effects are detrimental (Brinton, 2005; Suzuki et al., 2007).  This implies
that there is a critical window of estrogen sensitivity after ovariectomy or
menopause before the effects of long-term hypoestrogenicity become
irreversible(Maki, 2006).  Evidence for this critical period has been shown in
rodents, nonhuman primates, and women (Gibbs, 2000; Daniel et al., 2006;
Sherwin, 2006; Suzuki et al., 2007).  Most of the women in the WHI study
began taking hormones 10 or more years after menopause, long after the end
of the hypothesized critical period (Maki, 2006; Sherwin, 2006).  The effects
of estradiol on Akt and BDNF signaling in the young, healthy brain explored
in this thesis may not apply to the older, less healthy brain.
Second, different forms of estrogen and progesterone have been
explored for hormone replacement therapy in women, and they should not
be treated equally (Prestwood et al., 2004).  The form chosen for the WHI
study, CEE with or without MPA, is rarely used in laboratory studies.
Scientists have begun to consider the different biological actions of these
and other clinically relevant estrogenic compounds (Zhou et al., 2002;
Bernardi et al., 2003; Ciriza et al., 2004; O'Neill et al., 2004; Rhodes and
Frye, 2006; Zhao and Brinton, 2006).  In particular, the important role of ER
beta in estradiol effects in the hippocampus (Chapters 3 and 4 and (Liu et al.,
2008)) supports the design of human trials of selective estrogen receptor
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modulators with a higher affinity for ER beta than ER alpha.  These drugs
could maximize the cognitive benefits while minimizing unwanted side
effects of estrogen replacement therapy.
In addition to the issues of timing and hormone preparation, the
results in this thesis suggest that human studies may benefit from
considering genetic variation in the effects of hormone replacement.  If
common gene variants such as the BDNF Val66Met polymorphism can so
profoundly influence how estradiol acts in the brain, as suggested in Chapter
6, this knowledge could greatly increase the power of clinical trials.  Only
one such variant has so far been identified in humans, an ER alpha
polymorphism associated with the risk of cognitive decline (Yaffe et al.,
2002).  Animal studies may prove to be valuable models for elucidating the
specific roles of common human gene variants against an otherwise uniform
genetic background.
In sum, increased communication between basic and clinical scientists
in the wake of the WHI study has led to the development of several
principles that will be valuable in the design of future large-scale trials.
Hopefully, this experience will encourage continued conversation and more
efficient translation of laboratory findings.
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Concluding thoughts
With the burgeoning interest in translational medicine, laboratory
scientists must choose animal models carefully, with a mind toward the
clinical relevance of their experiments.  Questions pertaining to cognitive
decline or mood disorders following menopause or hysterectomy are best
explored using models of reproductive senescence such as ovariectomy.
Investigations of neurological or psychiatric disorders related to the
menstrual cycle, such as catamenial epilepsy or premenstrual dysphoric
disorder, benefit from the incorporation of naturally cycling animals.  The
most complete and informative studies will incorporate and compare several
different animal models and/or in vitro systems.
In addition to the endpoints explored in this thesis, other signaling
pathways and proteins surely play important roles in estradiol effects in the
hippocampal formation.  To study any of these players, reliable assays such
as the in situ hybridization and immunocytochemistry used in this study are
invaluable for the comparison of different hormone treatment paradigms and
genotypes.  In the future, more high-throughput methods would be welcome.
To be successful tools, these must consistently detect the small changes in
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protein expression or spine density, sometimes only 30% or 40%, which can
translate into huge differences in synapse number, plasticity, and behavior.
The neuroendocrinology of sex hormones is mystifyingly complex.
The effects of estradiol (or any hormone) in the brain are the result of
multiple actions, through multiple receptors, in different cell types and brain
regions.  The most easily measured effect may not be the most important
one, and no composite of molecular endpoints can substitute for a single
behavioral test.  But if we embrace the nuances of this system and seek to
understand them, we will be equipped for the most effective translation of





All animal procedures were approved by the Institutional Animal Care
and Use Committee of The Rockefeller University, Weill Cornell Medical
College, and/of the University of Tsukuba and were in accordance with the
NIH Guide for the Care and Use of Laboratory Animals. Animals were
housed on a 12-hour light/dark cycle with food and water available ad
libitum for the duration of the studies.  All mice used for these studies were
between the ages of 8 and 13 weeks.
Wild-type C57Bl6 mice were obtained from Taconic Farms, Inc.
(Germantown, NY) for estrous cycle characterization (Chapter 2); Charles
River Laboratories, Inc. (Wilmington, MA) for biochemical studies on
cycling mice (Chapters 3 and 4); and Jackson Laboratory (Bar Harbor, ME)
for electron microscopy studies (Chapter 5).
ER alpha knockout mice (ERKO) and ER beta knockout mice
(BERKO) were previously generated by targeted disruption of the ER alpha
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and beta genes.   For ER alpha, a NEO gene was inserted into exon 2 to
disrupt the reading frame (Lubahn et al., 1993). For ER beta, the NEO gene
was inserted in reverse order into exon 3, introducing several stop codons to
yield premature translation of the ER beta peptide (Krege et al., 1998).
These mice were mated onto a C57Bl/6J background.  The animals used for
these studies were bred and genotyped in collaboration with Sonoko Ogawa
at the University of Tsukuba, Japan.  In every experiment, homozygous
knockout mice were compared to wild-type littermates.
BDNF Val66Met mice were generated using a knock-in allele with
the point mutation G196A in the BDNF coding region as previously
described (Chen et al., 2006).  This mutation changes the Valine in position
66 to a Methionine. The mice were crossed onto a C57Bl/6J background for
at least 11 generations before these experiments, and were bred and
genotyped in collaboration with Francis Lee at Weill Cornell Medical




Vaginal swabs were taken daily between 9:30 and 10:30 AM and
vaginal cytology was observed under a microscope after staining with the
Hema 3 Stain Set from Fisher Scientific Company L.L.C. (Kalamazoo, MI).
Cycle phase was determined as proestrus, estrus, diestrus 1 or diestrus 2
according to published criteria (Turner and Bagnara, 1971b).  Mice without
progression through the distinct cytologic stages of proestrus, estrus and
diestrus were excluded from the studies.  Vaginal cytology was monitored
for at least one complete cycle before sacrifice or behavioral testing.  All
cycling mice were sacrificed in late morning, between the hours of 10:30
AM – 12:00 PM.  Uteri were dissected out and weighed.  Trunk blood was
collected into heparinized tubes, and plasma estradiol and progesterone were
measured using enzyme immunoassays from Endocrine Technologies, Inc.
(Newark, CA).
Ovariectomy and estrogen replacement
Mice were ovariectomized under isoflurane anesthesia and recovered
for one week from the surgery.  For the 6-hour treatment, subcutaneous
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injections of 100 µl vehicle (sesame oil) or 5 µg estradiol benzoate (EB) in
vehicle were then delivered six hours before sacrifice.  For 48-hour
treatment, two daily injections were given, and the mice sacrificed 24 hours
after the second injection.
Behavioral testing
Recognition tests. BDNF Val66Met mice underwent behavioral
testing on the novel object recognition (OR) and novel object placement
(OP) tasks as described previously ((Li et al., 2004), adapted from (Luine et
al., 2003)). Testing consisted of two five-minute trials, the sample and
recognition trials, separated by a delay.  During the sample trial of the OR
test, a mouse explored two novel, identical objects at one end of an open
field measuring 38.1 x 53.3.  The mouse was then returned to her home cage
for the delay period.  During the recognition trial, the mouse explored two
objects in the same locations.  One of the objects was identical to the sample
trial objects, and one was novel.  For the OP test, the two identical objects
used for the sample trial were familiar.  In the recognition trial, the objects
stayed the same, but one object was moved to a new location in the open
field.
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Mice were acclimated to the apparatus and OP objects before testing.
Once testing began, the mice were tested no more than once each day and at
least once every five days.  Each mouse was tested on the object placement
task once with a five-minute intertrial delay, and once with a thirty-minute
intertrial delay in each of the following estrous cycle stages: proestrus,
estrous, diestrus 1, and diestrus 2.  The same two objects were used
throughout OP testing.  Each mouse was testing on the OR task with a 30-
minute intertrial delay twice, with different object pairs.  Starting objects
(OR) or object start locations (OP) and new object locations (both OP and
OR) were counterbalanced across mice and trials. In the initial OP test and
the two OR tests, mice were in mixed estrous cycle stages.  Trials were
recorded and analyzed using the Noldus Ethovision XT software (Noldus
Information Technology, Leesburg, VA).  An area of 1 cm surrounding the
objects was delineated using the software, and object exploration was
defined as when the nose of the mouse was within this object surround area.
Quantitative and statistical analysis. To compare non-mnemonic
behaviors that may influence task performance, the following parameters
were measured from the sample trial: time spent in the center of the open
field, and time spent exploring objects.  Genotype differences on these
parameters were analyzed using a two-tailed t-test.  The effects of genotype
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and estrous cycle on these parameters were examined using two-way
ANOVA with genotype and cycle stage as the independent measures.
Statistical tests for these and all other data sets in this document were run
Prism GraphPad (version 5.0a for Macintosh). For the recognition trial, the
time spent exploring each object was measured. The amount of time spent
exploring the novel object (or object placement) during the recognition trial
was expressed as a fraction of the time spent with both objects, termed
“novel object fraction.”  A fraction of 0.5 is consistent with chance
performance; therefore, “recognition” was defined as a fraction significantly
greater than 0.5 (using a one-sample t-test).  Novel object fractions across
the estrous cycle were also analyzed using two-way ANOVA with genotype
and cycle stage as the independent measures.
Sacrifice
Mice were anesthetized with an overdose of sodium pentobarbital
(150 mg/kg intraperitoneal) and perfused through the aorta with
saline/heparin followed by 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4; PB).  Brains were removed from the skull and postfixed in 4%
paraformaldehyde for 1 hour.  They were then sunk in 30% sucrose in PB
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for 48 hours at 4°C, and frozen at -80°C until sectioning.  Sections (40 µm
thick) through the hippocampal formation were cut on a freezing microtome
(Microm HM440E).  Sections were stored in a cryoprotectant solution of
50% ethylene glycol, 15% sucrose in phosphate-buffered saline (PBS) until
use in immunohistochemical procedures.
For electron microscopy studies (Chapter 5), mice were perfused with
saline/heparin followed by 40 ml 3.75% acrolein and 2% paraformaldehyde
in 0.1 M phosphate buffer (PB), pH 7.4.  Brains were removed from the
skull and post-fixed for 30 minutes in 2% acrolein and 2%
paraformaldehyde solution in PB.  Coronal sections (40 µm thick) through
the dorsal hippocampal formation were cut on a vibrating microtome (Leica
Microsystems, Bannockburn, IL) and stored in 30% ethylene glycol and
30% sucrose in PB at -20°C.
For in situ hybridization studies on wild-type cycling mice (Chapter
4), mice were sacrificed via rapid decapitation and brains immediately
removed and frozen on dry ice. Coronal sections (20 µm thick) were cut on a
cryostat and stored on Superfrost Plus slides (Thermo Fisher Scientific, Inc.,
Waltham, MA) at -80°C.
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In situ hybridization
Antisense oligonucleotides matching the TrkB (5' TGC GAC TGC GTC
AGC TCG GTG GGC GGG TTC CCT CTG CCA TCA GCA CTG C 3') and
BDNF exon IX (5'GGG TTA CAC GAA GGA AGG CTG CAG GGG CAT
AGA CAA AAG GCA CTG GAA CT3') sequences were obtained from
Integrated DNA Technologies (Coralville, IA).  Control sense sequences
were also generated and used as a control to confirm a low level of
nonspecific interactions.  For studies on fresh frozen brains (Chapter 4), the
TrkB oligo was labeled with 35S and in situ hybridization was performed on
thawed slides containing sections through dorsal hippocampus and
ventromedial hypothalamus as described previously (Hunter et al., 2005).
Briefly, sections underwent the following washes: 4% paraformaldehyde,
phosphate-buffered saline (PBS), deionized water (dipped), 0.1 M
triethanolamine with 5ml/l acetic anhydride, salt–sodium citrate buffer
(SSC), in ascending concentrations of ethanol, chloroform, and 95% ethanol.
Sections were then air dried and incubated for 2 h with hybridization buffer
without probe, followed by one wash in 2X SSC, and one in 95% ethanol.
Sections were air dried and incubated overnight at 42°C with labeled probe
(0.5 x 106 counts per slide) diluted in 50% deionized formamide in
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hybridization buffer with dextran sulfate, denatured salmon testis DNA
(Sigma), and 200 mM dithiothreital. After hybridization, sections were
washed 4 times in SSC at 55 °C and left in SSC to cool to room temperature.
Final washes were as follows: 50% ethanol, 0.3 M ammonium acetate, 85%
ethanol, 0.3 M ammonium acetate, and 100% ethanol. Slides were then air
dried and exposed to Kodak MR autoradiography films.
For studies using sections from paraformaldehyde-perfused mice
(Chapter 6), floating sections containing dorsal hippocampus were mounted
on Fisher Superfrost Plus slides, washed in 0.05 M PB, and dried in a
desicator.  The oligos were labeled with 33P an in situ hybridization
conducted as above, starting after the formaldehyde fix step.
After exposure to film for one week (TrkB) or two weeks (BDNF), films
were developed and images taken on a light box using a CoolSnap camera.
In the hippocampus, optical density was measured from the CA1 (TrkB) and
CA3 (BDNF) pyramidal cell layers and normalized to background density
(stratum radiatum).  In the hypothalamus, optical density was measured from
the ventromedial nucleus and normalized to background density (white
matter).  Values from proestrus and diestrus mice were compared using a
two-tailed t-test; values from Val66met mice were compared using two-way
ANOVA with genotype and cycle phase as the independent variables.
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Immunocytochemistry and densitometry
Immunocytochemistry. Immunocytochemistry was performed on
sections through the dorsal hippocampal formation level 29 of Paxinos and
Watson (Paxinos and Watson, 1998) as previously described (Znamensky et
al., 2003).  For BDNF Val66Met mice, immunocytochemistry for PR was
also performed on sections through the medial preoptic area of the
hypothalamus.  To ensure identical labeling conditions, tissue from each
experimental conditions was marked with identifying punches and all
conditions were pooled during labeling procedures.  Moreover, tissue from
all mice was processed together for each study (Pierce et al., 1999).  Briefly,
sections were washed in 0.1 M Tris buffer, blocked in 0.5% bovine serum
albumin (BSA) and incubated in primary antiserum for 24 hours at room
temperature followed by 48 hours at 4°C.  Sections were then incubated in:
(1) biotinylated goat anti-rabbit or anti-mouse secondary antibody in 0.1%
BSA (1:400; Vector Labs, Burlingame, CA) for 30 minutes, avidin biotin
complex (ABC) for 30 minutes (Vector Labs, Burlingame, CA), and
diaminobenzidine with H2O2 (Aldrich, Milwaukee, WI) for 6 minutes, with
Tris washes in between each incubation.  Sections then were mounted on
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Superfrost Plus slides (Thermo Fisher Scientific, Waltham, MA), air-dried,
and coverslipped with DPX mounting medium (Aldrich, Milwaukee, WI).
Images for densitometric analysis were captured on a Nikon E800
microscope using a Dage CCD C72 camera and control unit using preset
gain and black levels, a Data Translation Quick capture card, and NIH
Image 1.50 software.  To compensate for uneven illumination, blank fields
from a slide without tissue were subtracted. To prepare figures, the levels,
brightness and contrast were adjusted in Adobe Photoshop 7.0 on a
Macintosh computer.  Final figures were assembled in Microsoft
Powerpoint.
For tissue from mice perfused with acrolein (Chapter 5), sections were
first washed in PB followed by 1% sodium borohydride in PB (30 minutes)
before proceeding to the first set of Tris washes and blocking step.  For
pTrkB peptide blocking control, antiserum was pre-adsorbed with excess
pTrkB blocking peptide.
Densitometry.  Quantitative Analysis was conducted using NIH
Image. The average pixel density (of 256 gray levels) was determined for
each selected region.  To compensate for background staining and control of
variations in illumination level between images, the average pixel density for
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3 small regions that lack labeling was determined within each captured
image, and subtracted from all density measurements made on that image.
The resulting relative optical densities (ROD) from were compared between
cycle phases using Analysis of Variance or two-way Analysis of Variance.
Post-hoc comparisons were made using Bonferroni tests.
Cell counting. To count PR-positive cells in the MPO of BDNF
Val66Met mice, the MPO was identified on a light microscope.  PR-positive
cells were counted in a fixed-area polygon using Neurolucida software from
both hemispheres.
Antibodies. The following antibodies were used for
immunocytochemistry. Serial dilution tests of each antibody established that
the labeling intensity was linear, and antibody dilutions were chosen that
produced slightly less than half-maximal labeling intensity to optimize the
detection of intensity variations (Chang et al., 2000).
Polyclonal rabbit anti-ER alpha (1:20,000) was a gift from the S.
Hayashi laboratory. This antibody has been shown to recognize both
ligand-bound and unbound receptors (Okamura et al., 1992; Alves et
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al., 1998).  Specificity of this antibody was verified by Western
blotting, peptide pre-adsorption, and pre-immune serum (Milner et al.,
2001).
Polyclonal rabbit anti-ER beta (1:10,000) was obtained from Merck
Research Laboratories (Rahway, NJ).  The specificity of this antibody
was verified using secondary-only immunocytochemistry and peptide
pre-adsorption (Milner et al., 2005).
Monoclonal mouse anti-PSD-95 (1:20,000) was purchased from
Sigma (St. Louis, MO).
Polyclonal rabbit anti-phosphothreonine 308 Akt (1:1500) was
purchased from Cell Signaling Technology (Danvers, MA).
Specificity of the antibody was confirmed by Western blot and
peptide preadsorption in acrolein/paraformaldehyde-fixed tissue
(Znamensky et al., 2003).
Polyclonal rabbit anti-phosphotyrosine 816 TrkB (1:1000-5000) was a
gift from Moses Chao at New York University.  Specificity of this
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antibody was confirmed by Western Blot (Arevalo et al., 2006) and
peptide pre-adsorption (Chapter 5).
Polyclonal guinea pig anti-dynorphin (1:2000) was purchased from
Bachem AG (Torrance, CA).  Specificity of this antibody was verified
by peptide pre-adsorption (Svingos et al., 1999).
Polyclonal rabbit anti-progesterone receptor (1:500) was purchased
from Dako North America, Inc. (Carpinteria, CA). Specificity of this
antibody was demonstrated by using knockout-mice and peptide
preadsorption (Waters et al., 2008).
Pre-embedding immuno-electron microscopy
Immunocytochemistry and tissue preparation. Labeling was
conducted as described above for acrolein-fixed tissue. To verify the
localization and more discretely visualize the immunoreactivity, a few
sections were labeled using gold particles conjugated to secondary antibody
(Chan et al., 1990).  Instead of the secondary antisera described above, these
sections were incubated in colloidal gold-labeled (1 nM) goat anti-rabbit IgG
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(1:50; Electron Microscopy Sciences, Fort Washington, PA) in 0.08% BSA,
0.01% gelatin in PB with 0.9% saline (PBS) for two hours at room
temperature.  These sections were post-fixed in 2% glutaraldehyde in PBS
for 10 minutes followed by 0.2 M sodium citrate buffer (pH 7.4).  Gold
labeling was enhanced using a silver solution (IntenSE; Amersham,
Piscataway, NJ).
To determine whether pTrkB labeled mossy fiber axon bundles and
terminals in CA3, a few sections were double-labeled for pTrkB and
dynorphin, an opioid peptide contained exclusively in mossy fiber axons and
terminals in the CA3 (Drake et al., 2007).  First, tissue was labeled with
pTrkB primary antiserum (1:2000) as described above.  Tissue was then
incubated in dynorphin primary antiserum (1:2000) with 0.025% Triton for
48 hours at 4°C.  pTrkB labeling was then completed using the ABC
protocol as described above. Dynorphin labeling was completed using
colloidal gold-labeled anti-guinea pig IgG (1:50) for the secondary
antiserum as described above for pTrkB (Chan et al., 1990).
Sections for electron microscopy were incubated in 2% osmium
tetroxide (one hour) and dehydrated in an alcohol series and propylene
oxide.  They then were then embedded in EMBed 812 (Electron Microscopy
Sciences, Hatfield, PA) between two sheets of plastic (Chan et al., 1990).
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One embedded section from 3 animals in each group (proestrus, estrus,
diestrus, and male) was selected and mounted on Epon chucks.  Ultrathin
70-nm sections within 1.5 mm of the tissue surface were cut on a Leica UTC
Ultratome (Leica Microsystems, Bannockburn, IL), collected on grids, and
counterstained with uranyl acetate and Reynold’s lead citrate.  Sections were
examined on a Tecnai Biotwin transmission electron microscope (FEI
Company, Hillsboro, OR) and images acquired using Advanced Microscopy
Techniques software (v. 3.2).  Digital images for figures were cropped and
adjusted for levels, brightness, contrast, and sharpness in Adobe Photoshop
7.0, and final figures were assembled in Photoshop and Powerpoint.
Quantitative Analysis. From each block, a 220.5 µm2 of neuropil was
examined from each of the following hippocampal laminae: stratum oriens,
stratum radiatum (proximal to the pyramidal cell layer), stratum radiatum
(distal from the pyramidal cell layer), and lacunosum moleculare of CA1;
stratum oriens, stratum lucidum, and stratum radiatum of CA3; outer,
middle, and inner thirds of the molecular layer, subgranular zone, and
central hilus of the dentate gyrus.  The distribution of labeled profiles was
determined by counting immunolabeled profiles, which were classified using
accepted nomenclature (Peters et al., 1991). Dendrites contained
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microtubular arrays and synaptic contacts with adjacent axon terminals.
Spines had a smaller diameter than dendrites (usually less than 0.2 µm) and
contacted neighboring axon terminals.  Unmyelinated axons had a small
diameter (less than 0.2 µm), few vesicles, and no synaptic contacts in the
plane of section.  Axon terminals had a larger diameter than axons,
contained numerous vesicles, and made synaptic contacts with neighboring
dendritic spines or shafts.  Glial profiles contained no microtubules and
conformed to the shape of surrounding structures.  Each hippocampal lamina
contained a similar distribution of profile types, limiting the possibility of
sampling error when comparing the distribution of profiles between animals.
In addition to the labeled profiles, all unlabeled axon terminals and dendritic
spines were counted in the CA1 stratum radiatum (distal) from pTrkB-
labeled sections to determine the percentage of axon terminals and dendritic
spines containing pTrkB-ir.
Statistical Analysis.  For each block (animal), the number of pTrkB-
labeled profiles in each cell compartment within one lamina was expressed
as a percentage of the total counted profiles in the whole hippocampal
formation, and as a percentage of the total counted profiles and in that
particular hippocampal subregion (CA1, CA3, or dentate gyrus).  Means for
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each estrous cycle group and males were compared using two-way ANOVA
and Bonferroni post-hoc tests in Prism 5.0 software.  The number of labeled
axon terminals and dendritic spines in distal CA1 stratum radiatum was
expressed as a percentage of the total terminals or spines in this lamina.  The
proportion of labeled axons and terminals were compared among groups
using one-way ANOVA and Bonferroni post-hoc tests.
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